[go: up one dir, main page]

TWI559076B - Curable resin composition - Google Patents

Curable resin composition Download PDF

Info

Publication number
TWI559076B
TWI559076B TW101140949A TW101140949A TWI559076B TW I559076 B TWI559076 B TW I559076B TW 101140949 A TW101140949 A TW 101140949A TW 101140949 A TW101140949 A TW 101140949A TW I559076 B TWI559076 B TW I559076B
Authority
TW
Taiwan
Prior art keywords
meth
formula
copolymer
acid
acrylate
Prior art date
Application number
TW101140949A
Other languages
Chinese (zh)
Other versions
TW201335696A (en
Inventor
白川政和
Original Assignee
住友化學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 住友化學股份有限公司 filed Critical 住友化學股份有限公司
Publication of TW201335696A publication Critical patent/TW201335696A/en
Application granted granted Critical
Publication of TWI559076B publication Critical patent/TWI559076B/en

Links

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/0045Photosensitive materials with organic non-macromolecular light-sensitive compounds not otherwise provided for, e.g. dissolution inhibitors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00Compositions of unspecified macromolecular compounds
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/1303Apparatus specially adapted to the manufacture of LCDs
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/09Photosensitive materials characterised by structural details, e.g. supports, auxiliary layers
    • G03F7/11Photosensitive materials characterised by structural details, e.g. supports, auxiliary layers having cover layers or intermediate layers, e.g. subbing layers

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Nonlinear Science (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Structural Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Architecture (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Materials For Photolithography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Optical Filters (AREA)
  • Paints Or Removers (AREA)

Description

硬化性樹脂組成物 Curable resin composition

本發明是有關硬化性樹脂組成物。 The present invention relates to a curable resin composition.

近年的液晶顯示之顯示裝置中,為了形成光間隙材料(PhotoSpacer)、及保護塗布層等的硬化膜,而使用硬化性樹脂組成物。作為如此之硬化性樹脂組成物者,己知是含有將二乙二醇乙基甲基醚與3-甲氧基-1-丁醇與丙二醇單甲基醚當作溶劑之組成物(JP2010-152335A)。 In the display device for liquid crystal display in recent years, a curable resin composition is used in order to form a photo-gap material (PhotoSpacer) and a cured film such as a protective coating layer. As such a curable resin composition, it is known to contain a composition of diethylene glycol ethyl methyl ether and 3-methoxy-1-butanol and propylene glycol monomethyl ether as a solvent (JP2010- 152335A).

自以往所提案的硬化性樹脂組成物,係在基板上塗布該硬化性樹脂組成物後,於減壓乾燥之際的乾燥時間必需要很長,並且也有不能充分滿足的情形。 Since the curable resin composition which has been proposed in the past is coated with the curable resin composition on the substrate, the drying time at the time of drying under reduced pressure must be long and may not be sufficiently satisfied.

本發明是含有以下的發明。 The present invention contains the following invention.

[1]一種硬化性樹脂組成物,係包含具硬化性的樹脂與溶劑,其中,溶劑為含有二烷二醇二烷基醚、與溶劑(E1)、與溶劑(E2),二烷二醇二烷基醚的含量,相對於溶劑的總量,為1質量%以上至45質量%以下。 [1] A curable resin composition comprising a curable resin and a solvent, wherein the solvent contains a dialkyl glycol dialkyl ether, a solvent (E1), a solvent (E2), and a dialkyl glycol. The content of the dialkyl ether is from 1% by mass to 45% by mass based on the total amount of the solvent.

溶劑(E1):與二烷二醇二烷基醚不同,並且蒸發速度是將醋酸丁酯之蒸發速度當作100時,溶劑(E1)的蒸發速度為40以上至100以下的溶劑,溶劑(E2):與二烷二醇二烷基醚不同,並且蒸發速度是將醋酸丁酯之蒸發速度當作100時,溶劑(E2)的蒸發速度為13以上至未達40的溶劑。 Solvent (E1): different from dialkyl glycol dialkyl ether, and evaporation rate is a solvent when the evaporation rate of butyl acetate is taken as 100, and the evaporation rate of solvent (E1) is 40 or more and 100 or less, solvent ( E2): Unlike the dialkyl glycol dialkyl ether, and the evaporation rate is a solvent in which the evaporation rate of the butyl acetate is regarded as 100, the evaporation rate of the solvent (E2) is 13 or more to less than 40.

[2]如[1]所述之硬化性樹脂組成物,其中,有硬化性的樹脂係包含源自由不飽和羧酸及不飽和羧酸酐所成群組中選出之至少一種的結構單元,與源自具有碳數2至4的環狀醚結構及烯性不飽和鍵的單體之結構單元的共聚合物。 [2] The curable resin composition according to [1], wherein the curable resin is a structural unit containing at least one selected from the group consisting of a source of a free unsaturated carboxylic acid and an unsaturated carboxylic anhydride; A copolymer derived from a structural unit of a monomer having a cyclic ether structure having 2 to 4 carbon atoms and an ethylenically unsaturated bond.

[3]如[1]或[2]所述之硬化性樹脂組成物,其復含有抗氧化劑。 [3] The curable resin composition according to [1] or [2] which further contains an antioxidant.

[4]一種硬化膜,由前述[1]至[3]中任何一項所述之硬化性樹脂組成物而形成。 [4] A cured film formed of the curable resin composition according to any one of the above [1] to [3].

[5]一種顯示裝置,含有[4]所述之硬化膜。 [5] A display device comprising the cured film according to [4].

[6]一種硬化膜之製造方法,含有(1)將[1]至[3]之任一項所述之硬化性樹脂組成物在基板上塗布的步驟,(2)將塗布之硬化性樹脂組成物減壓乾燥,形成組成物層的步驟,及(3)將組成物層加熱的步驟。 [6] A method for producing a cured film, comprising: (1) a step of coating the curable resin composition according to any one of [1] to [3] on a substrate, and (2) applying the curable resin. The composition is dried under reduced pressure to form a composition layer, and (3) a step of heating the composition layer.

依本發明的話,可能提供在基板上塗布硬化性樹脂組成物後,於減壓乾燥之際的乾燥時間短的硬化性樹脂組成物。 According to the present invention, it is possible to provide a curable resin composition having a short drying time when the curable resin composition is applied onto a substrate and dried under reduced pressure.

[實施發明之最佳形態] [Best Mode for Carrying Out the Invention]

本說明書中,作為各成分例示之化合物,無特別限制時,可以單獨或是組合複數種而使用。 In the present specification, the compounds exemplified as the respective components are not particularly limited, and may be used singly or in combination of plural kinds.

本發明的硬化性樹脂組成物是包含具硬化性的樹脂(以下有稱「樹脂(A)」的情形)及溶劑(E), 溶劑(E)是含有二烷二醇二烷基醚、與溶劑(E1)、與溶劑(E2), 二烷二醇二烷基醚的含量,相對於溶劑的總量,為1質量%以上至45質量%以下的硬化性樹脂組成物。 The curable resin composition of the present invention contains a curable resin (hereinafter referred to as "resin (A)") and a solvent (E). The solvent (E) is a dialkyl glycol dialkyl ether, a solvent (E1), and a solvent (E2). The content of the dialkyl glycol dialkyl ether is from 1% by mass to 45% by mass based on the total amount of the solvent.

溶劑(E1):與二烷二醇二烷基醚不同,並且蒸發速度是將醋酸丁酯之蒸發速度當作100時,溶劑(E1)的蒸發速度為40以上至100以下的溶劑,溶劑(E2):與二烷二醇二烷基醚不同,並且蒸發速度是將醋酸丁酯之蒸發速度當作100時,溶劑(E2)的蒸發速度為13以上至未達40的溶劑。 Solvent (E1): different from dialkyl glycol dialkyl ether, and evaporation rate is a solvent when the evaporation rate of butyl acetate is taken as 100, and the evaporation rate of solvent (E1) is 40 or more and 100 or less, solvent ( E2): Unlike the dialkyl glycol dialkyl ether, and the evaporation rate is a solvent in which the evaporation rate of the butyl acetate is regarded as 100, the evaporation rate of the solvent (E2) is 13 or more to less than 40.

又,本發明的硬化性樹脂組成物,較佳係含有下述所成群組中選出之至少1種成分:丙烯醯基及甲基丙烯醯基所成群組中選出之至少1種之基(以下有稱為「(甲基)丙烯醯基」之情形)的化合物(以下有稱為「(甲基)丙烯系化合物(B)」之情形)、抗氧化劑(F)、及界面活性劑(H)。 Further, the curable resin composition of the present invention preferably contains at least one selected from the group consisting of at least one selected from the group consisting of an acryloyl group and a methacryl group. (There are compounds called "(meth)acryloyl group)" (hereinafter referred to as "(meth)propene compound (B)"), antioxidant (F), and surfactant (H).

又,本發明的硬化性樹脂組成物也可以含有下述所 成群組中選出之至少1種成分:由縮水甘油醚型環氧樹脂及縮水甘油酯型環氧樹脂所成群組中選出之至少1種的環氧樹脂(以下有稱為「環氧樹脂(C)」之情形)、聚合起始劑(D)、聚合起始助劑(D1)、硫醇化合物(T)、由多元羧酸酐及多價羧酸所成群組中選出之至少一種的化合物(以下有稱為「多元羧酸(G)」之情形)、及咪唑化合物(J)。 Further, the curable resin composition of the present invention may contain the following At least one component selected from the group consisting of at least one epoxy resin selected from the group consisting of a glycidyl ether type epoxy resin and a glycidyl ester type epoxy resin (hereinafter referred to as "epoxy resin" (C)", a polymerization initiator (D), a polymerization initiation aid (D1), a thiol compound (T), at least one selected from the group consisting of a polycarboxylic acid anhydride and a polyvalent carboxylic acid The compound (hereinafter referred to as "polycarboxylic acid (G)") and the imidazole compound (J).

〈樹脂(A)〉 <Resin (A)>

樹脂(A)是有硬化性之樹脂,以熱硬化性樹脂為佳,以60℃以上的熱而硬化之樹脂為較佳,以含有源自由不飽和羧酸及不飽和羧酸酐所成群組中選出之至少1種(以下有稱為「(a)」之情形)的結構單元、與源自具有碳數2至4的環狀醚結構及烯性不飽和鍵的單體(以下有稱為「(b)」之情形)之結構單元的共聚合物為更佳。又,該共聚合物也可具有可與(a)共聚合,並且源自沒有碳數2至4的環狀醚結構之單體(以下,有稱為「(c)」之情形)」的結構單元。 The resin (A) is a curable resin, preferably a thermosetting resin, preferably a resin which is cured by heat of 60 ° C or higher, and a group containing a source of a free unsaturated carboxylic acid and an unsaturated carboxylic anhydride. A structural unit selected from at least one of the following (hereinafter referred to as "(a)"), and a monomer derived from a cyclic ether structure having a carbon number of 2 to 4 and an ethylenically unsaturated bond (hereinafter referred to as The copolymer of the structural unit which is the case of "(b)" is more preferable. Further, the copolymer may have a monomer which can be copolymerized with (a) and derived from a cyclic ether structure having no carbon number of 2 to 4 (hereinafter, referred to as "(c)"). Structural units.

樹脂(A)理想的是以下之樹脂「K1」及樹脂「K2」。 The resin (A) is preferably the following resin "K1" and resin "K2".

樹脂「K1」:(a)與(b)之共聚合物;樹脂「K2」:(a)與(b)與(c)之共聚合物。 Resin "K1": a copolymer of (a) and (b); a resin "K2": a copolymer of (a) and (b) and (c).

作為(a)者,例如可以列舉:丙烯酸、甲基丙烯酸、巴豆酸、o-、m-、p-乙烯基安息香酸等不飽和單羧酸類;馬來酸、富馬酸、檸康酸、中康酸、衣康酸、3-乙烯基苯二甲酸、4-乙烯基苯二甲酸、3,4,5,6-四氫苯二甲酸、1,2,3,6-四氫苯二甲酸、二甲基四氫苯二甲酸、1,4-環己烯基二羧酸等不飽和羧酸類; 甲基-5-降冰片烯-2,3-二羧酸、5-羧基雙環[2,2,1]庚-2-烯、5,6-二羧基雙環[2,2,1]庚-2-烯、5-羧基-5-甲基雙環[2,2,1]庚-2-烯、5-羧基-5-乙基雙環[2,2,1]庚-2-烯、5-羧基-6-甲基雙環[2,2,1]庚-2-烯、5-羧基-6-乙基雙環[2,2,1]庚-2-烯等之含有羧基之雙環不飽和化合物類;馬來酸酐、檸康酸酐、衣康酸酐、3-乙烯基苯二甲酸酐、4-乙烯基苯二甲酸酐、3,4,5,6-四氫苯二甲酸酐、1,2,3,6-四氫苯二甲酸酐、二甲基四氫苯二甲酸酐、5,6-二羧基雙環[2,2,1]庚-2-烯無水物等不飽和二羧酸類無水物;琥珀酸單[2-(甲基)丙烯醯氧乙基]酯、苯二甲酸單[2-(甲基)丙烯醯氧乙基]酯等之2價以上之多元羧酸的不飽和單[(甲基)丙烯醯氧烷基]酯類。 Examples of (a) include unsaturated monocarboxylic acids such as acrylic acid, methacrylic acid, crotonic acid, o-, m-, and p-vinylbenzoic acid; maleic acid, fumaric acid, citraconic acid, and the like. Zhongkang acid, itaconic acid, 3-vinyl phthalic acid, 4-vinyl phthalic acid, 3,4,5,6-tetrahydrophthalic acid, 1,2,3,6-tetrahydrobenzene An unsaturated carboxylic acid such as formic acid, dimethyltetrahydrophthalic acid or 1,4-cyclohexenyl dicarboxylic acid; Methyl-5-norbornene-2,3-dicarboxylic acid, 5-carboxybicyclo[2,2,1]hept-2-ene, 5,6-dicarboxybicyclo[2,2,1]heptane- 2-ene, 5-carboxy-5-methylbicyclo[2,2,1]hept-2-ene, 5-carboxy-5-ethylbicyclo[2,2,1]hept-2-ene, 5- A carboxyl group-containing bicyclic unsaturated compound such as carboxy-6-methylbicyclo[2,2,1]hept-2-ene or 5-carboxy-6-ethylbicyclo[2,2,1]hept-2-ene Class; maleic anhydride, citraconic anhydride, itaconic anhydride, 3-vinyl phthalic anhydride, 4-vinyl phthalic anhydride, 3,4,5,6-tetrahydrophthalic anhydride, 1,2 , 3,6-tetrahydrophthalic anhydride, dimethyltetrahydrophthalic anhydride, 5,6-dicarboxybicyclo[2,2,1]hept-2-ene anhydrate, etc., unsaturated dicarboxylic acid anhydrous Unsaturation of divalent or higher polycarboxylic acids such as succinic acid mono [2-(methyl) propylene oxyethyl] ester, phthalic acid mono [2-(methyl) propylene oxyethyl] ester Mono[(meth)acryloxyalkyl]esters.

α-(羥基甲基)丙烯酸等,在同一分子中含有羥基及羧基的不飽和丙烯酸類等。 An unsaturated acrylic acid or the like which contains a hydroxyl group and a carboxyl group in the same molecule, such as α-(hydroxymethyl)acrylic acid.

此等之中,從對共聚合反應性或鹼水溶液的溶解性觀點而言,係以(甲基)丙烯酸及馬來酸酐為佳,以(甲基)丙烯酸為更佳。 Among these, from the viewpoint of solubility in the copolymerization reactivity or the aqueous alkali solution, (meth)acrylic acid and maleic anhydride are preferred, and (meth)acrylic acid is more preferred.

又,在本說明書中,「(甲基)丙烯醯基」是表示選自丙烯醯基及甲基丙烯醯基所成群組中至少1種。「(甲基)丙烯酸」及「(甲基)丙烯酸酯」等之表示,也有同樣的意義。 In the present specification, "(meth)acrylonitrile" means at least one selected from the group consisting of an acryloyl group and a methacryloyl group. The expressions "(meth)acrylic acid" and "(meth)acrylate" have the same meaning.

(b)例如是碳數2至4的環狀醚結構(例如,選自環氧乙烷環、氧雜環丁烷環及四氫呋喃環所成群組中至少1種)與有烯性不飽和鍵的聚合性化合物。(b)是以有碳數2至4的環狀醚與(甲基)丙烯醯氧基之單體為佳。 (b) is, for example, a cyclic ether structure having 2 to 4 carbon atoms (for example, at least one selected from the group consisting of an oxirane ring, an oxetane ring, and a tetrahydrofuran ring) and an olefinic unsaturated group. A polymerizable compound of a bond. (b) It is preferred to use a cyclic ether having 2 to 4 carbon atoms and a monomer having a (meth)acryloxy group.

作為(b)者,例如,可以列舉:有環氧乙基與烯性不飽和鍵的單體(b1)(以下有稱為「(b1)」的情形)、有氧雜環丁基與烯性不飽和鍵的單體(b2)(以下有稱為「(b2)」的情形)、有四氫呋喃基與烯性不飽和鍵的單體(b3)(以下有稱為「(b3)」的情形)。 (b), for example, a monomer (b1) having an epoxy group and an ethylenically unsaturated bond (hereinafter referred to as "(b1)"), an aoxetanyl group and an alkene a monomer (b2) having an unsaturated bond (hereinafter referred to as "(b2)"), a monomer (b3) having a tetrahydrofuranyl group and an ethylenically unsaturated bond (hereinafter referred to as "(b3)") situation).

(b1)例如,可以列舉:有直鏈狀或分枝鏈狀之不飽和脂肪族烴為被環氧化結構之單體(b1-1)(以下有稱為「(b1-1)」之情形),及有不飽和脂環式烴為被環氧化結構之單體(b1-2)(以下有稱為「(b1-2)」之情形)。 (b1) For example, a case where the unsaturated aliphatic hydrocarbon having a linear or branched chain shape is a monomer (b1-1) having an epoxidized structure (hereinafter referred to as "(b1-1)" And the unsaturated alicyclic hydrocarbon is a monomer (b1-2) having an epoxidized structure (hereinafter referred to as "(b1-2)").

作為(b1-1)者,可以列舉:縮水甘油基(甲基)丙烯酸酯、β-甲基縮水甘油基(甲基)丙烯酸酯、β-乙基縮水甘油基(甲基)丙烯酸酯、縮水甘油基乙烯基醚、o-乙烯基苄基縮水甘油基醚、m-乙烯基苄基縮水甘油基醚、p-乙烯基苄基縮水甘油基醚、α-甲基-o-乙烯基苄基縮水甘油基醚、α-甲基-m-乙烯基苄基縮水甘油基醚、α-甲基-p-乙烯基苄基縮水甘油基醚、2,3-雙(縮水甘油基氧基甲基)苯乙烯、2,4-雙(縮水甘油基氧基甲基)苯乙烯、2,5-雙(縮水甘油基氧基甲基)苯乙烯、2,6-雙(縮水甘油基氧基甲基)苯乙烯、2,3,4-參(縮水甘油基氧基甲基)苯乙烯、2,3,5-參(縮水甘油基氧基甲基)苯乙烯、3,4,5-參(縮水甘油基氧基甲基)苯乙烯、2,4,6-參(縮水甘油基氧基甲基)苯乙烯等。 Examples of (b1-1) include glycidyl (meth) acrylate, β-methyl glycidyl (meth) acrylate, β-ethyl glycidyl (meth) acrylate, and shrinkage. Glyceryl vinyl ether, o-vinylbenzyl glycidyl ether, m-vinylbenzyl glycidyl ether, p-vinylbenzyl glycidyl ether, α-methyl-o-vinyl benzyl Glycidyl ether, α-methyl-m-vinylbenzyl glycidyl ether, α-methyl-p-vinylbenzyl glycidyl ether, 2,3-bis(glycidyloxymethyl) Styrene, 2,4-bis(glycidyloxymethyl)styrene, 2,5-bis(glycidyloxymethyl)styrene, 2,6-bis(glycidyloxy) Styrene, 2,3,4-glycol (glycidyloxymethyl)styrene, 2,3,5-gin (glycidyloxymethyl)styrene, 3,4,5-para (Glycidyloxymethyl)styrene, 2,4,6-gin (glycidyloxymethyl)styrene, and the like.

作為(b1-2)者,可以列舉:乙烯基環己烯單氧化物、1,2-環氧基-4-乙烯基環己烷(例如:Celloxide 2000;Daicel化學工業(股)製)、(甲基)丙烯酸3,4-環氧基環己基甲基酯(例如,Cyclomer-A400;Diacel化學工業(股)製)、(甲基)丙烯酸3,4-環氧基環己基甲基酯(例如,Cyclomer-M100;Daicel化學工業(股)製)、式 (1)所示化合物及式(11)所示化合物。 Examples of the (b1-2) include vinylcyclohexene monooxide and 1,2-epoxy-4-vinylcyclohexane (for example, Celloxide 2000; manufactured by Daicel Chemical Industry Co., Ltd.). 3,4-Epoxycyclohexylmethyl (meth)acrylate (for example, Cyclomer-A400; manufactured by Diacel Chemical Industry Co., Ltd.), 3,4-epoxycyclohexylmethyl (meth)acrylate (for example, Cyclomer-M100; Daicel Chemical Industry Co., Ltd.) (1) A compound represented by the formula (11).

[式(I)及式(II)中,Rb1及Rb2是表示氫原子、或碳數1至4的烷基,在該烷基中所含氫原子也可以用羥基取代;Xb1及Xb2是表示單鍵、-Rb3-、*-Rb3-O-、*-Rb3-S-、或是*-Rb3-NH-。Rb3表示碳數1至6的烷二基;*是表示與O的結合鍵。] [In the formulae (I) and (II), R b1 and R b2 are a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, and a hydrogen atom contained in the alkyl group may be substituted with a hydroxyl group; X b1 and X b2 represents a single bond, -R b3 -, * - R b3 -O -, * - R b3 -S-, or * -R b3 -NH-. R b3 represents an alkanediyl group having 1 to 6 carbon atoms; * is a bond indicating a bond with O. ]

作為碳數1至4的烷基者,可以列舉:甲基、乙基、n-丙基、異丙基、n-丁基、二級丁基、三級丁基等。 Examples of the alkyl group having 1 to 4 carbon atoms include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a secondary butyl group, and a tertiary butyl group.

作為氫原子以羥基取代之烷基者,可以列舉:羥基甲基、1-羥基乙基、2-羥基乙基、1-羥基丙基、2-羥基丙基、3-羥基丙基、1-羥基-1-甲基乙基、2-羥基-1-甲基乙基、1-羥基丁基、2-羥基丁基、3-羥基丁基、4-羥基丁基等。 Examples of the alkyl group in which the hydrogen atom is substituted with a hydroxyl group include a hydroxymethyl group, a 1-hydroxyethyl group, a 2-hydroxyethyl group, a 1-hydroxypropyl group, a 2-hydroxypropyl group, a 3-hydroxypropyl group, and a 1-hydroxy group. Hydroxy-1-methylethyl, 2-hydroxy-1-methylethyl, 1-hydroxybutyl, 2-hydroxybutyl, 3-hydroxybutyl, 4-hydroxybutyl, and the like.

作為Rb1及Rb2者,理想的是可以列舉:氫原子、甲基、羥基甲基、1-羥基乙基及2-羥基乙基,更佳的是氫原子、甲基。 As R b1 and R b2 , a hydrogen atom, a methyl group, a hydroxymethyl group, a 1-hydroxyethyl group and a 2-hydroxyethyl group are preferable, and a hydrogen atom or a methyl group is more preferable.

作為烷二基者,可以列舉:亞甲基、伸乙基、丙烷-1,2二基、丙烷-1,3二基、丁烷-1,4二基、戊烷-1,5二基、己烷-1,6二基等。 As the alkanediyl group, a methylene group, an ethylidene group, a propane-1,2diyl group, a propane-1,3diyl group, a butane-1,4diyl group, a pentane-1,5-diyl group can be exemplified. , hexane-1,6 diyl and the like.

作為Xb1及Xb2者,理想的可以列舉:單鍵、亞甲基、伸乙基、*-CH2-O-及*-CH2CH2-O-,更佳的是單鍵、及*-CH2CH2-O-。 *是表示與O的結合鍵。 Preferred examples of X b1 and X b2 include a single bond, a methylene group, an ethylidene group, *-CH 2 -O-, and *-CH 2 CH 2 -O-, more preferably a single bond, and *-CH 2 CH 2 -O-. * is a bond indicating the bond with O.

作為式(I)所示化合物者,可以列舉:式(I-1)至式(I-15)的任何一個所示的化合物等。其中,以式(I-1)、式(I-3)、式(I-5)、式(I-7)、式(I-9)、或式(I-11)至式(I-15)所示化合物為佳。以式(I-1)、式(I-7)、式(I-9)、或式(I-15)所示化合物為更佳。 The compound represented by the formula (I) may, for example, be a compound represented by any one of the formulae (I-1) to (I-15). Wherein, the formula (I-1), the formula (I-3), the formula (I-5), the formula (I-7), the formula (I-9), or the formula (I-11) to the formula (I- 15) The compound shown is preferred. The compound represented by the formula (I-1), the formula (I-7), the formula (I-9) or the formula (I-15) is more preferably.

作為式(II)所示化合物者,可以列舉:式(II-1)至式(II-15)的任何一個所示的化合物等。其中,以式(II-1)、式(II-3)、式(II-5)、式(II-7)、式(II-9)、或式(II-11)至式(II-15)所示化合物為佳。以式(II-1)、式(II-7)、式(II-9)、或式(II-15)所示化合物為更佳。 The compound represented by the formula (II) may, for example, be a compound represented by any one of the formulae (II-1) to (II-15). Wherein, the formula (II-1), the formula (II-3), the formula (II-5), the formula (II-7), the formula (II-9), or the formula (II-11) to the formula (II- 15) The compound shown is preferred. A compound represented by the formula (II-1), the formula (II-7), the formula (II-9), or the formula (II-15) is more preferred.

式(I)所示化合物及式(II)所示化合物,可以是分別單獨使用,也可以以任意比率混合而使用。混合使用的情形,式(I)所示化合物及式(II)所示化合物的含有比率以莫耳基準,理想的是5:95至95:5,較佳的是10:90至90:10,更佳的是20:80至80:20。 The compound represented by the formula (I) and the compound represented by the formula (II) may be used singly or in combination at any ratio. In the case of mixing, the content of the compound represented by the formula (I) and the compound of the formula (II) is on a molar basis, preferably from 5:95 to 95:5, preferably from 10:90 to 90:10. More preferably, it is 20:80 to 80:20.

作為(b2)者,以有氧雜環丁基與(甲基)丙烯醯氧基單體為更佳。 As the (b2), an oxetanyl group and a (meth) acryloxy group are more preferable.

作為(b2)者,可以列舉:3-甲基-3-甲基丙烯醯氧基甲基氧雜環丁烷、3-甲基-3-丙烯醯氧基甲基氧雜環丁烷、3-乙基-3-甲基丙烯醯氧基甲基氧雜環丁烷、3-乙基-3-丙烯醯氧基甲基氧雜環丁烷、3-甲基-3-甲基丙烯醯氧基乙基氧雜環丁烷、3-甲基-3-丙烯醯氧基乙基氧雜環丁烷、3-乙基-3-甲基丙烯醯氧基乙基氧雜環丁烷、3-乙基-3-丙烯醯氧基乙基氧雜環丁烷等。 Examples of the (b2) include 3-methyl-3-methylpropenyloxymethyloxetane, 3-methyl-3-propenyloxymethyloxetane, and 3 -ethyl-3-methylpropenyloxymethyloxetane, 3-ethyl-3-propenyloxymethyloxetane, 3-methyl-3-methylpropene oxime Oxyethyl oxetane, 3-methyl-3-propenyloxyethyloxetane, 3-ethyl-3-methylpropenyloxyethyloxetane, 3-ethyl-3-propenyloxyethyloxetane and the like.

作為(b3)者,以有四氫呋喃基與(甲基)丙烯醯氧基之單體為佳。作為(b3)者,可以列舉:丙烯酸四氫呋喃基酯(例如:Biscoat V#150,大阪有機化學工業(股)製)、甲基丙烯酸四氫呋喃基酯等。 As the (b3), a monomer having a tetrahydrofuranyl group and a (meth)acryloxy group is preferred. The (b3) may, for example, be tetrahydrofuranyl acrylate (for example, Biscoat V#150, manufactured by Osaka Organic Chemical Industry Co., Ltd.) or tetrahydrofuranyl methacrylate.

作為(b)者,從所得硬化膜的耐熱性、耐藥品性等的可信度高觀點而言,以有(b1)為佳。又,從硬化性樹脂組成物的保存安定性優之觀點而言,以有(b1-2)為佳。 (b) is preferably (b1) from the viewpoint of high reliability such as heat resistance and chemical resistance of the obtained cured film. Moreover, it is preferable to have (b1-2) from the viewpoint of excellent storage stability of the curable resin composition.

作為(c)者,例如,可以列舉:(甲基)丙烯酸甲基酯、(甲基)丙烯酸乙基酯、(甲基)丙烯酸n-丁基酯、(甲基)丙烯酸二級丁基酯、(甲基)丙烯酸三級丁基酯、(甲基)丙烯酸2-乙基己基酯、(甲基)丙烯酸十二烷基酯、(甲基)丙烯酸月桂基酯、(甲基)丙烯酸硬脂基酯、(甲基)丙烯酸環戊基酯、(甲基)丙烯酸環己基酯、(甲基)丙烯酸2-甲基環己基酯、三環[5,2,1,02.6]癸-8-基(甲基)丙烯酸酯(在該技術領域,以「(甲基)丙烯酸二環戊基酯」之慣用名稱之,又,有稱為「(甲基)丙烯酸三環癸酯」的情形。)、(甲基)丙烯酸三環[5,2,1,02.6]癸烯-8-基酯(在該技術領域,以「(甲基)丙烯酸二環戊烯基酯」之慣用名稱之的情形。)、(甲基)丙烯酸二環戊基氧乙基酯、(甲基)丙烯酸異降冰片基酯、(甲基)丙烯酸金剛基酯、(甲基)丙烯酸烯丙基酯、(甲基)丙烯酸丙炔基酯、(甲基)丙烯酸苯基酯、(甲基)丙烯酸萘基酯、(甲基)丙烯酸苄基酯等(甲基)丙烯酸酯類;(甲基)丙烯酸2-羥基乙基酯、(甲基)丙烯酸2-羥基丙基酯等含有羥基的(甲基)丙烯酸酯類;馬來酸二乙酯、富馬酸二乙酯、衣康酸二乙酯等二羧酸二酯;雙環[2,2,1]庚-2-烯、5-甲基雙環[2,2,1]庚-2-烯、5-乙基雙環[2,2,1]庚-2-烯、5-羥基雙環[2,2,1]庚-2-烯、5-羥基甲基雙環[2,2,1]庚-2-烯、5-(2'-羥基乙基)雙環[2,2,1]庚-2-烯、5-甲氧基雙環 [2,2,1]庚-2-烯、5-乙氧基雙環[2,2,1]庚-2-烯、5,6-二羥基雙環[2,2,1]庚-2-烯、5,6-二(羥基甲基)雙環[2,2,1]庚-2-烯、5,6-二(2'-羥基乙基)雙環[2,2,1]庚-2-烯、5,6-二甲氧基雙環[2,2,1]庚-2-烯、5,6-二乙氧基雙環[2,2,1]庚-2-烯、5-羥基-5-甲基雙環[2,2,1]庚-2-烯、5-羥基-5-乙基雙環[2,2,1]庚-2-烯、5-羥基甲基-5-甲基雙環[2,2,1]庚-2-烯、5-三級丁氧基羰基雙環[2,2,1]庚-2-烯、5-環己氧基羰基雙環[2,2,1]庚-2-烯、5-苯氧基羰基雙環[2,2,1]庚-2-烯、5,6-雙(三級丁氧基羰基)雙環[2,2,1]庚-2-烯、5,6-雙(環已氧基羰基)雙環[2,2,1]庚-2-烯等雙環不飽和化合物類;N-苯基馬來醯亞胺、N-環己基馬來醯亞胺、N-苄基馬來醯亞胺、N-琥珀醯亞胺基-3-馬來醯亞胺苯甲酸酯、N-琥珀醯亞胺基-4-馬來醯亞胺丁酸酯、N-琥珀醯亞胺基-6-馬來醯亞胺己酸酯、N-琥珀醯亞胺基-3-馬來醯亞胺丙酸酯、N-(9-吖啶基)馬來醯亞胺等二羰基醯亞胺衍生物類;苯乙烯、α-甲基苯乙烯、o-乙烯基甲苯、m-乙烯基甲苯、p-乙烯基甲苯、p-甲氧基苯乙烯、丙烯腈、甲基丙烯腈、氯化乙烯、偏氯化乙烯、丙烯醯胺、甲基丙烯醯胺、醋酸乙烯酯、1,3-丁二烯、異戊二烯、2,3-二甲基-1,3-丁二烯等。 As (c), for example, methyl (meth)acrylate, ethyl (meth)acrylate, n-butyl (meth)acrylate, and n-butyl (meth)acrylate may be mentioned. , (butyl) (meth) acrylate, 2-ethylhexyl (meth) acrylate, dodecyl (meth) acrylate, lauryl (meth) acrylate, (meth) acrylate a lipid ester, cyclopentyl (meth)acrylate, cyclohexyl (meth)acrylate, 2-methylcyclohexyl (meth)acrylate, tricyclo[5,2,1,0 2.6 ]癸- 8-based (meth) acrylate (in the technical field, the conventional name of "dicyclopentyl (meth) acrylate", and also known as "tricyclodecyl (meth) acrylate) Case.), Tricyclo[5,2,1,0 2.6 ]decene-8-yl (meth)acrylate (in the technical field, the use of "dicyclopentenyl (meth)acrylate" The name of the case.), (cyclo) oxyethyl (meth) acrylate, isobornyl (meth) acrylate, adamantyl (meth) acrylate, allyl (meth) acrylate , propynyl (meth) acrylate, phenyl (meth) acrylate, (A) (meth) acrylate such as naphthyl acrylate or benzyl (meth) acrylate; 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate, etc. (meth) acrylates; dicarboxylic acid diesters such as diethyl maleate, diethyl fumarate, diethyl itaconate; bicyclo[2,2,1]hept-2-ene, 5-methylbicyclo[2,2,1]hept-2-ene, 5-ethylbicyclo[2,2,1]hept-2-ene, 5-hydroxybicyclo[2,2,1]hept-2 - alkene, 5-hydroxymethylbicyclo[2,2,1]hept-2-ene, 5-(2'-hydroxyethyl)bicyclo[2,2,1]hept-2-ene, 5-methoxy Bicyclo[2,2,1]hept-2-ene, 5-ethoxybicyclo[2,2,1]hept-2-ene, 5,6-dihydroxybicyclo[2,2,1]heptane- 2-ene, 5,6-bis(hydroxymethyl)bicyclo[2,2,1]hept-2-ene, 5,6-bis(2'-hydroxyethyl)bicyclo[2,2,1]g 2-ene, 5,6-dimethoxybicyclo[2,2,1]hept-2-ene, 5,6-diethoxybicyclo[2,2,1]hept-2-ene, 5 -hydroxy-5-methylbicyclo[2,2,1]hept-2-ene, 5-hydroxy-5-ethylbicyclo[2,2,1]hept-2-ene, 5-hydroxymethyl-5 -Methylbicyclo[2,2,1]hept-2-ene, 5-tris-butoxycarbonylbicyclo[2,2,1]hept-2-ene, 5-cyclohexyloxycarbonylbicyclo[2, 2,1]hept-2-ene, 5-benzene Oxycarbonylbicyclo[2,2,1]hept-2-ene, 5,6-bis(tertiary butoxycarbonyl)bicyclo[2,2,1]hept-2-ene, 5,6-bis ( a bicyclic unsaturated compound such as cyclohexyloxycarbonyl)bicyclo[2,2,1]hept-2-ene; N-phenylmaleimide, N-cyclohexylmaleimide, N-benzyl Maleic imine, N-succinimide-3-maleimide benzoate, N-succinimide-4-maleimide butyrate, N-amber Dicarbonyl such as amino-6-maleimide caproate, N-succinimide-3-maleimide propionate, N-(9-acridinyl)maleimide Yttrium derivatives; styrene, α-methylstyrene, o-vinyltoluene, m-vinyltoluene, p-vinyltoluene, p-methoxystyrene, acrylonitrile, methacrylonitrile , chlorinated ethylene, vinylidene chloride, acrylamide, methacrylamide, vinyl acetate, 1,3-butadiene, isoprene, 2,3-dimethyl-1,3-butyl Diene, etc.

此等之中,從共聚合反應性及耐熱性觀點而言,以苯乙烯、乙烯基甲苯、N-苯基馬來醯亞胺、N-環己基馬來醯亞胺及N-苄基馬來醯亞胺、雙環[2,2,1]庚-2-烯為佳。 Among these, styrene, vinyl toluene, N-phenylmaleimide, N-cyclohexylmaleimide, and N-benzyl horse are used from the viewpoints of copolymerization reactivity and heat resistance. It is preferred to carry out the imine and bicyclo[2,2,1]hept-2-ene.

樹脂[K1]中,源自各別單體之結構單元的比率,相對於構成樹脂[K1]的全結構單元,是以源自(a)之結構單元:5至60莫耳% 源自(b)之結構單元:40至95莫耳%為理想,以源自(a)之結構單元:10至50莫耳%源自(b)之結構單元:50至90莫耳%為更佳。 In the resin [K1], the ratio of the structural unit derived from the respective monomers is a structural unit derived from (a) with respect to the entire structural unit constituting the resin [K1]: 5 to 60 mol% The structural unit derived from (b): 40 to 95 mol% is ideal, and the structural unit derived from (a): 10 to 50 mol% derived from the structural unit of (b): 50 to 90 mol% Better.

構成樹脂[K1]之結構單元的比率,在上述範圍內時,硬化性樹脂組成物的保存安定性,得到之硬化膜之耐藥品性、耐熱性及機械強度有優異的傾向。 When the ratio of the structural unit constituting the resin [K1] is within the above range, the storage stability of the curable resin composition tends to be excellent in chemical resistance, heat resistance and mechanical strength of the cured film.

樹脂[K1],例如,可以參考在文獻「高分子合成之實驗法」(大津隆行著 發行所:化學同人(股)第1版第1刷1972年3月1日發行)所記載的方法及在該文獻記載的引用文獻來製造。 Resin [K1], for example, can be referred to the method described in the "Experimental Method for Polymer Synthesis" (Otsuka Ryokan, Ltd.: Chemicals (People's), 1st Edition, 1st Brush, March 1, 1972) It is manufactured by the cited documents described in this document.

具體上,可以列舉,將(a)及(b)的所定量、聚合起始劑及溶劑等放入反應容器中,例如,藉由利用氮氣替換氧氣,作成脫氧環境,一面攪拌,一面加熱及保溫的方法。又,在此使用的聚合起始劑及溶劑等是無特別之限制,可以使用在該領域通常使用者。作為聚合起始劑者,例如,可以列舉:偶氮化合物(2,2'-偶氮雙異丁腈、2.2'-偶氮(2,4-二甲基戊腈)等),或有機過氧化物(過氧化苯甲醯等)。作為溶劑者,只要可以溶解各單體者即可,可以列舉後述之在硬化性樹脂組成物中使用的溶劑等。 Specifically, the quantitative amount, the polymerization initiator, the solvent, and the like of (a) and (b) are placed in a reaction container, for example, by replacing oxygen with nitrogen to form a deoxidizing environment, and heating while stirring The method of insulation. Further, the polymerization initiator, the solvent and the like used herein are not particularly limited, and can be used as a general user in the field. As the polymerization initiator, for example, an azo compound (2,2'-azobisisobutyronitrile, 2.2'-azo (2,4-dimethylvaleronitrile), etc.) or organic Oxide (benzaldehyde peroxide, etc.). The solvent is not particularly limited as long as it can dissolve each monomer, and examples thereof include a solvent used in the curable resin composition described later.

又,得到的樹脂,可以直接使用反應後之溶液,也可以使用已濃縮過或是稀釋過之溶液,也可以使用以再沉澱等之方法中作為固體(粉體)而取出者。尤其,作為聚合溶劑者,藉由在本發明的硬化性樹脂組成物中使用之溶劑,由於可以將反應後 之溶液在製造硬化性樹脂組成物中直接使用,故可以簡化硬化性樹脂組成物之製造步驟。 Further, as the obtained resin, the solution after the reaction may be used as it is, or a solution which has been concentrated or diluted may be used, or a solid (powder) may be taken out by a method such as reprecipitation. In particular, as a polymerization solvent, the solvent used in the curable resin composition of the present invention can be used after the reaction Since the solution is used as it is in the production of the curable resin composition, the production steps of the curable resin composition can be simplified.

樹脂[K2]中,源自各別結構單元的比率,相對於構成樹脂[K2]的全結構單元中,是以源自(a)之結構單元:2至40莫耳%源自(b)之結構單元:2至95莫耳%源自(c)之結構單元:1至65莫耳%為理想,以源自(a)之結構單元:5至35莫耳%源自(b)之結構單元:5至80莫耳%源自(c)之結構單元:1至60莫耳%為更佳。 In the resin [K2], the ratio derived from the respective structural units is based on the structural unit derived from (a) with respect to the entire structural unit constituting the resin [K2]: 2 to 40 mol% is derived from (b) The structural unit: 2 to 95 mol% of the structural unit derived from (c): 1 to 65 mol% is ideal, and the structural unit derived from (a): 5 to 35 mol% is derived from (b) The structural unit: 5 to 80 mol% derived from the structural unit of (c): 1 to 60 mol% is more preferable.

又,源自(a)之結構單元與源自(b)之結構單元的合計量,相對於構成樹脂[K2]之全結構單元的合計莫耳數,是以70至99莫耳%為佳,以在90至99莫耳%為更佳。 Further, the total amount of the structural unit derived from (a) and the structural unit derived from (b) is preferably 70 to 99 mol% with respect to the total number of moles of the entire structural unit constituting the resin [K2]. To be more preferably at 90 to 99 mol%.

構成樹脂[K2]之結構單元的比率,為在上述範圍內時,硬化性樹脂組成物的保存安定性,得到之硬化膜之耐藥品性、耐熱性及機械強度有優異的傾向。 When the ratio of the structural unit constituting the resin [K2] is within the above range, the storage stability of the curable resin composition tends to be excellent, and the cured film is excellent in chemical resistance, heat resistance, and mechanical strength.

樹脂[K2]是可以藉由與樹脂[K1]同樣的方法來製造。 The resin [K2] can be produced by the same method as the resin [K1].

作為樹脂[K1]的具體例者,可以列舉:(甲基)丙烯酸/式(I-1)所示化合物(以下有略稱「式(I-1)」之情形。式(I-2)等、其他也同樣)之共聚物、(甲基)丙烯酸/式(I-2)之共聚物、(甲基)丙烯酸/式(I-3)之共聚物、(甲基)丙烯酸/式(I-4)之共聚物、(甲基)丙烯酸/式(I-5)之共聚物、(甲基)丙烯酸/式(I-6)之共聚物、(甲基)丙烯酸/ 式(I-7)之共聚物、(甲基)丙烯酸/式(I-8)之共聚物、(甲基)丙烯酸/式(I-9)之共聚物、(甲基)丙烯酸/式(I-10)之共聚物、(甲基)丙烯酸/式(I-11)之共聚物、(甲基)丙烯酸/式(I-12)之共聚物、(甲基)丙烯酸/式(I-13)之共聚物、(甲基)丙烯酸/式(I-14)之共聚物、(甲基)丙烯酸/式(I-15)之共聚物、(甲基)丙烯酸/式(II-1)之共聚物、(甲基)丙烯酸/式(II-2)之共聚物、(甲基)丙烯酸/式(II-3)之共聚物、(甲基)丙烯酸/式(II-4)之共聚物、(甲基)丙烯酸/式(II-5)之共聚物、(甲基)丙烯酸/式(II-6)之共聚物、(甲基)丙烯酸/式(II-7)之共聚物、(甲基)丙烯酸/式(II-8)之共聚物、(甲基)丙烯酸/式(II-9)之共聚物、(甲基)丙烯酸/式(II-10)之共聚物、(甲基)丙烯酸/式(II-11)之共聚物、(甲基)丙烯酸/式(II-12)之共聚物、(甲基)丙烯酸/式(II-13)之共聚物、(甲基)丙烯酸/式(II-14)之共聚物、(甲基)丙烯酸/式(II-15)之共聚物、(甲基)丙烯酸/式(I-1)/式(II-1)之共聚物、(甲基)丙烯酸/式(I-2)/式(II-2)之共聚物、(甲基)丙烯酸/式(I-3)/式(II-3)之共聚物、(甲基)丙烯酸/式(I-4)/式(II-4)之共聚物、(甲基)丙烯酸/式(I-5)/式(II-5)之共聚物、(甲基)丙烯酸/式(I-6)/式(II-6)之共聚物、(甲基)丙烯酸/式(I-7)/式(II-7)之共聚物、(甲基)丙烯酸/式(I-8)/式(II-8)之共聚物、(甲基)丙烯酸/式(I-9)/式(II-9)之共聚物、(甲基)丙烯酸/式(I-10)/式(II-10)之共聚物、(甲基)丙烯酸/式(I-11)/式(II-11)之共聚物、(甲基)丙烯酸/式(I-12)/式(II-12)之共聚物、(甲基)丙烯酸/式(I-13)/式(II-13)之共聚物、(甲基)丙烯酸/(I-14)/式(II-14)之共聚物、(甲基)丙烯酸/式(I-15)/式(II-15)之共聚物、(甲基)丙烯酸/式(I-1)/式(I-7)之共聚物、(甲基)丙烯酸/式(I-1)/式(II-7)之共聚物、巴豆酸/式(I-1)之共聚物、巴豆酸/式(I-2)之共聚物、巴豆酸/式(I-3)之共聚物、巴豆酸/式(I-4)之共 聚物、巴豆酸/式(I-5)之共聚物、巴豆酸/式(I-6)之共聚物、巴豆酸/式(I-7)之共聚物、巴豆酸/式(I-8)之共聚物、巴豆酸/式(I-9)之共聚物、巴豆酸/式(I-10)之共聚物、巴豆酸/式(I-11)之共聚物、巴豆酸/式(I-12)之共聚物、巴豆酸/式(I-13)之共聚物、巴豆酸/式(I-14)之共聚物、巴豆酸/式(I-15)之共聚物、巴豆酸/式(II-1)之共聚物、巴豆酸/式(II-2)之共聚物、巴豆酸/式(II-3)之共聚物、巴豆酸/式(II-4)之共聚物、巴豆酸/式(II-5)之共聚物、巴豆酸/式(II-6)之共聚物、巴豆酸/式(II-7)之共聚物、巴豆酸/式(II-8)之共聚物、巴豆酸/式(II-9)之共聚物、巴豆酸/式(II-10)之共聚物、巴豆酸/式(II-11)之共聚物、巴豆酸/式(II-12)之共聚物、巴豆酸/式(II-13)之共聚物、巴豆酸/式(II-14)之共聚物、巴豆酸/式(II-15)之共聚物、馬來酸/式(I-1)之共聚物、馬來酸/式(I-2)之共聚物、馬來酸/式(I-3)之共聚物、馬來酸/式(I-4)之共聚物、馬來酸/式(I-5)之共聚物、馬來酸/式(I-6)之共聚物、馬來酸/式(I-7)之共聚物、馬來酸/式(I-8)之共聚物、馬來酸/式(I-9)之共聚物、馬來酸/式(I-10)之共聚物、馬來酸/式(I-11)之共聚物、馬來酸/式(I-12)之共聚物、馬來酸/式(I-13)之共聚物、馬來酸/式(I-14)之共聚物、馬來酸/式(I-15)之共聚物、馬來酸/式(II-1)之共聚物、馬來酸/式(II-2)之共聚物、馬來酸/式(II-3)之共聚物、馬來酸/式(II-4)之共聚物、馬來酸/式(II-5)之共聚物、馬來酸/式(II-6)之共聚物、馬來酸/式(II-7)之共聚物、馬來酸/式(II-8)之共聚物、馬來酸/式(II-9)之共聚物、馬來酸/式(II-10)之共聚物、馬來酸/式(II-11)之共聚物、馬來酸/式(II-12)之共聚物、馬來酸/式(II-13)之共聚物、馬來酸/式(II-14)之共聚物、馬來酸/式(II-15)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-1)之共聚物、(甲基)丙烯酸/馬來酸酐/式 (I-2)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-3)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-4)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-5)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-6)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-7)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-8)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-9)之共聚物、(甲基)丙烯酸酐/馬來酸酐/式(I-10)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-11)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-12)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-13)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-14)之共聚物、(甲基)丙烯酸/馬來酸酐/式(I-15)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-1)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-2)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-3)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-4)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-5)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-6)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-7)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-8)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-9)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-10)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-11)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-12)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-13)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-14)之共聚物、(甲基)丙烯酸/馬來酸酐/式(II-15)之共聚物等。 Specific examples of the resin [K1] include a compound represented by (meth)acrylic acid/formula (I-1) (hereinafter, abbreviated as "formula (I-1)". Formula (I-2) Copolymer of (method, etc.), (meth)acrylic acid / copolymer of formula (I-2), (meth)acrylic acid / copolymer of formula (I-3), (meth)acrylic acid / formula ( Copolymer of I-4), (meth)acrylic acid / copolymer of formula (I-5), (meth)acrylic acid / copolymer of formula (I-6), (meth)acrylic acid / Copolymer of the formula (I-7), (meth)acrylic acid / copolymer of the formula (I-8), (meth)acrylic acid / copolymer of the formula (I-9), (meth)acrylic acid / formula ( Copolymer of I-10), (meth)acrylic acid / copolymer of formula (I-11), (meth)acrylic acid / copolymer of formula (I-12), (meth)acrylic acid / formula (I- 13) copolymer, (meth)acrylic acid / copolymer of formula (I-14), (meth)acrylic acid / copolymer of formula (I-15), (meth)acrylic acid / formula (II-1) Copolymer, (meth)acrylic acid / copolymer of formula (II-2), (meth)acrylic acid / copolymer of formula (II-3), copolymerization of (meth)acrylic acid / formula (II-4) , (meth)acrylic acid / copolymer of formula (II-5), (meth)acrylic acid / copolymer of formula (II-6), (meth)acrylic acid / copolymer of formula (II-7), (Meth)acrylic acid / copolymer of the formula (II-8), (meth)acrylic acid / copolymer of the formula (II-9), (meth)acrylic acid / copolymer of the formula (II-10), (A) Acrylic acid / copolymer of formula (II-11), (meth)acrylic acid / copolymer of formula (II-12), (meth)acrylic acid / copolymer of formula (II-13), (methyl) Acrylic acid / copolymer of formula (II-14), (meth)acrylic acid / copolymer of formula (II-15), (methyl Acrylic acid / copolymer of formula (I-1) / formula (II-1), (meth)acrylic acid / copolymer of formula (I-2) / formula (II-2), (meth)acrylic acid / (I-3) / copolymer of the formula (II-3), (meth)acrylic acid / copolymer of the formula (I-4) / formula (II-4), (meth)acrylic acid / formula (I-5) Copolymer of formula (II-5), (meth)acrylic acid / copolymer of formula (I-6) / formula (II-6), (meth)acrylic acid / formula (I-7) / formula ( Copolymer of II-7), (meth)acrylic acid / copolymer of formula (I-8) / formula (II-8), (meth)acrylic acid / formula (I-9) / formula (II-9) Copolymer, (meth)acrylic acid / copolymer of formula (I-10) / formula (II-10), (meth)acrylic acid / copolymer of formula (I-11) / formula (II-11), (Meth)acrylic acid / copolymer of formula (I-12) / formula (II-12), (meth)acrylic acid / copolymer of formula (I-13) / formula (II-13), (methyl) Acrylic acid / (I-14) / copolymer of formula (II-14), (meth)acrylic acid / copolymer of formula (I-15) / formula (II-15), (meth)acrylic acid / formula (I -1) / copolymer of the formula (I-7), (meth)acrylic acid / copolymer of the formula (I-1) / formula (II-7), crotonic acid / copolymer of the formula (I-1), Crotonic acid / copolymer of formula (I-2), copolymer of crotonic acid / formula (I-3), crotonic acid / formula (I-4) Polymer, crotonic acid / copolymer of formula (I-5), crotonic acid / copolymer of formula (I-6), crotonic acid / copolymer of formula (I-7), crotonic acid / formula (I-8 Copolymer, crotonic acid / copolymer of formula (I-9), crotonic acid / copolymer of formula (I-10), crotonic acid / copolymer of formula (I-11), crotonic acid / formula (I -12) copolymer, crotonic acid / copolymer of formula (I-13), crotonic acid / copolymer of formula (I-14), crotonic acid / copolymer of formula (I-15), crotonic acid / formula (II-1) copolymer, crotonic acid / copolymer of formula (II-2), crotonic acid / copolymer of formula (II-3), crotonic acid / copolymer of formula (II-4), crotonic acid / copolymer of formula (II-5), crotonic acid / copolymer of formula (II-6), crotonic acid / copolymer of formula (II-7), crotonic acid / copolymer of formula (II-8), Crotonic acid / copolymer of formula (II-9), copolymer of crotonic acid / formula (II-10), copolymer of crotonic acid / formula (II-11), copolymerization of crotonic acid / formula (II-12) , crotonic acid / copolymer of formula (II-13), crotonic acid / copolymer of formula (II-14), crotonic acid / copolymer of formula (II-15), maleic acid / formula (I-1 Copolymer, maleic acid / copolymer of formula (I-2), maleic acid / copolymer of formula (I-3), Malay / copolymer of formula (I-4), copolymer of maleic acid / formula (I-5), copolymer of maleic acid / formula (I-6), maleic acid / formula (I-7) Copolymer, maleic acid / copolymer of formula (I-8), copolymer of maleic acid / formula (I-9), copolymer of maleic acid / formula (I-10), maleic acid / formula Copolymer of (I-11), copolymer of maleic acid/formula (I-12), copolymer of maleic acid/formula (I-13), copolymer of maleic acid/formula (I-14) , maleic acid / copolymer of formula (I-15), copolymer of maleic acid / formula (II-1), copolymer of maleic acid / formula (II-2), maleic acid / formula (II -3) copolymer, maleic acid / copolymer of formula (II-4), copolymer of maleic acid / formula (II-5), copolymer of maleic acid / formula (II-6), horse Copolymer / copolymer of formula (II-7), copolymer of maleic acid / formula (II-8), copolymer of maleic acid / formula (II-9), maleic acid / formula (II-10) Copolymer, maleic acid / copolymer of formula (II-11), copolymer of maleic acid / formula (II-12), copolymer of maleic acid / formula (II-13), maleic acid / copolymer of formula (II-14), copolymer of maleic acid / formula (II-15), (meth)acrylic acid / maleic anhydride / copolymer of formula (I-1), (meth)acrylic acid /maleic anhydride / type (I-2) copolymer, (meth)acrylic acid/maleic anhydride/copolymer of formula (I-3), (meth)acrylic acid/maleic anhydride/copolymer of formula (I-4), Methyl)acrylic acid/maleic anhydride/copolymer of formula (I-5), (meth)acrylic acid/maleic anhydride/copolymer of formula (I-6), (meth)acrylic acid/maleic anhydride/form (I-7) copolymer, (meth)acrylic acid/maleic anhydride/copolymer of formula (I-8), (meth)acrylic acid/maleic anhydride/copolymer of formula (I-9), Methyl)acrylic anhydride/maleic anhydride/copolymer of formula (I-10), (meth)acrylic acid/maleic anhydride/copolymer of formula (I-11), (meth)acrylic acid/maleic anhydride/ a copolymer of the formula (I-12), a copolymer of (meth)acrylic acid/maleic anhydride/formula (I-13), a copolymer of (meth)acrylic acid/maleic anhydride/formula (I-14), (Meth)acrylic acid/maleic anhydride/copolymer of formula (I-15), (meth)acrylic acid/maleic anhydride/copolymer of formula (II-1), (meth)acrylic acid/maleic anhydride/ a copolymer of the formula (II-2), a copolymer of (meth)acrylic acid/maleic anhydride/formula (II-3), a copolymer of (meth)acrylic acid/maleic anhydride/formula (II-4), Copolymerization of (meth)acrylic acid/maleic anhydride/formula (II-5) , (meth)acrylic acid/maleic anhydride/copolymer of formula (II-6), (meth)acrylic acid/maleic anhydride/copolymer of formula (II-7), (meth)acrylic acid/malay Anhydride/copolymer of formula (II-8), copolymer of (meth)acrylic acid/maleic anhydride/formula (II-9), copolymerization of (meth)acrylic acid/maleic anhydride/formula (II-10) , (meth)acrylic acid/maleic anhydride/copolymer of formula (II-11), (meth)acrylic acid/maleic anhydride/copolymer of formula (II-12), (meth)acrylic acid/Malay Anhydride/copolymer of formula (II-13), copolymer of (meth)acrylic acid/maleic anhydride/formula (II-14), copolymerization of (meth)acrylic acid/maleic anhydride/formula (II-15) Things and so on.

作為樹脂[K2]的具體例者,可以列舉:(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-2)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-3)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-4)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-5)/(甲基)丙烯酸甲基酯之共聚合 物、(甲基)丙烯酸/式(I-6)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-7)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-8)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-9)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-10)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-11)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-12)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-13)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-14)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-15)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-2)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-3)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-4)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-5)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-6)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-7)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-8)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-9)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-10)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-11)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-12)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-13)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-14)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(II-15)/(甲基)丙烯酸甲基酯之共聚合物、(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸二環戊基酯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸二環戊基酯之共聚合物、(甲基)丙烯酸/式(I-1)/式(II-1)/(甲 基)丙烯酸二環戊基酯之共聚合物、巴豆酸/式(I-1)/(甲基)丙烯酸二環戊基酯之共聚合物、馬來酸/式(I-1)/(甲基)丙烯酸二環戊基酯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(I-1)/(甲基)丙烯酸二環戊基酯之共聚合物、(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸甲基酯/(甲基)丙烯酸二環戊基酯之共聚合物、巴豆酸/式(II-1)/(甲基)丙烯酸二環戊基酯之共聚合物、馬來酸/式(II-1)/(甲基)丙烯酸二環戊基酯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(II-1)/(甲基)丙烯酸二環戊基酯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸甲基酯/(甲基)丙烯酸二環戊基酯之共聚合物、(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸苯基酯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸苯基酯之共聚合物、(甲基)丙烯酸/式(I-1)/式(II-1)/(甲基)丙烯酸苯基酯之共聚合物、巴豆酸/式(I-1)/(甲基)丙烯酸苯基酯之共聚合物、馬來酸/式(I-1)/(甲基)丙烯酸苯基酯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(I-1)/(甲基)丙烯酸苯基酯之共聚合物、(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸甲基酯/(甲基)丙烯酸苯基酯之共聚合物、巴豆酸/式(II-1)/(甲基)丙烯酸苯基酯之共聚合物、馬來酸/式(II-1)/(甲基)丙烯酸苯基酯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(II-1)/(甲基)丙烯酸苯基酯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸甲基酯/(甲基)丙烯酸苯基酯之共聚合物、(甲基)丙烯酸/式(I-1)/馬來酸二乙酯之共聚合物、(甲基)丙烯酸/式(II-1)/馬來酸二乙酯之共聚合物、(甲基)丙烯酸/式(I-1)/式(II-1)/馬來酸二乙酯之共聚合物、巴豆酸/式(I-1)/馬來酸二乙酯之共聚合物、馬來酸/式(I-1)/馬來酸二乙酯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(I-1)/馬來酸二乙酯之共聚合物、(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸甲基酯/馬來酸二乙酯 之共聚合物、巴豆酸/式(II-1)/馬來酸二乙酯之共聚合物、馬來酸/式(II-1)/馬來酸二乙酯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(II-1)/馬來酸二乙酯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸甲基酯/馬來酸二乙酯之共聚合物、(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸2-羥基乙基酯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸2-羥基乙基酯之共聚合物、(甲基)丙烯酸/式(I-1)/式(II-1)/(甲基)丙烯酸2-羥基乙基酯之共聚合物、巴豆酸/式(I-1)/(甲基)丙烯酸2-羥基乙基酯之共聚合物、馬來酸/式(I-1)/(甲基)丙烯酸2-羥基乙基酯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(I-1)/(甲基)丙烯酸2-羥基乙基酯之共聚合物、(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸甲基酯/(甲基)丙烯酸2-羥基乙基酯之共聚合物、巴豆酸/式(II-1)/(甲基)丙烯酸2-羥基乙基酯之共聚合物、馬來酸/式(II-1)/(甲基)丙烯酸2-羥基乙基酯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(II-1)/(甲基)丙烯酸2-羥基乙基酯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸甲基酯/(甲基)丙烯酸2-羥基乙基酯之共聚合物、(甲基)丙烯酸/式(I-1)/雙環[2,2,1]庚-2-烯之共聚合物、(甲基)丙烯酸/式(II-1)/雙環[2,2,1]庚-2-烯之共聚合物、(甲基)丙烯酸/式(I-1)/式(II-1)/雙環[2,2,1]庚-2-烯之共聚合物、巴豆酸/式(I-1)/雙環[2,2,1]庚-2-烯之共聚合物、馬來酸/式(I-1)/雙環[2,2,1]庚-2-烯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(I-1)/雙環[2,2,1]庚-2-烯之共聚合物、(甲基)丙烯酸/式(I-1)/甲基(甲基)丙烯酸酯/雙環[2,2,1]庚-2-烯之共聚合物、巴豆酸/式(II-1)/雙環[2,2,1]庚-2-烯之共聚合物、馬來酸/式(II-1)/雙環[2,2,1]庚-2-烯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(II-1)/雙環[2,2,1]庚-2-烯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸甲 基酯/雙環[2,2,1]庚-2-烯之共聚合物、(甲基)丙烯酸/式(I-1)/N-環己基馬來醯亞胺之共聚合物、(甲基)丙烯酸/式(II-1)/N-環己基馬來醯亞胺之共聚合物、(甲基)丙烯酸/式(I-1)/式(II-1)/N-環己基馬來醯亞胺之共聚合物、巴豆酸/式(I-1)/N-環己基馬來醯亞胺之共聚合物、馬來酸/式(I-1)/N-環己基馬來醯亞胺之共聚合物、(甲基)丙烯酸/馬來酸酐/式(I-1)/N-環己基馬來醯亞胺之共聚合物、(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸甲基酯/N-環己基馬來醯亞胺之共聚合物、巴豆酸/式(II-1)/N-環己基馬來醯亞胺之共聚合物、馬來酸/式(II-1)/N-環己基馬來醯亞胺之共聚合物、(甲基)丙烯酸/馬來酸酐/式(II-1)/N-環己基馬來醯亞胺之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸甲基酯/N-環己基馬來醯亞胺之共聚合物、(甲基)丙烯酸/式(I-1)/苯乙烯之共聚合物、(甲基)丙烯酸/式(II-1)/苯乙烯之共聚合物、(甲基)丙烯酸/式(I-1)/式(II-1)/苯乙烯之共聚合物、巴豆酸/式(I-1)/苯乙烯之共聚合物、馬來酸/式(I-1)/苯乙烯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(I-1)/苯乙烯之共聚合物、(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸甲基酯/苯乙烯之共聚合物、巴豆酸/式(II-1)/苯乙烯之共聚合物、馬來酸/式(II-1)/苯乙烯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(II-1)/苯乙烯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸甲基酯/苯乙烯之共聚合物、(甲基)丙烯酸/式(I-1)/N-環己基馬來醯亞胺/苯乙烯之共聚合物、(甲基)丙烯酸/式(II-1)/N-環己基馬來醯亞胺/苯乙烯之共聚合物、(甲基)丙烯酸/式(I-1)/式(II-1)/N-環己基馬來醯亞胺/苯乙烯之共聚合物、巴豆酸/式(I-1)/N-環己基馬來醯亞胺/苯乙烯之共聚合物、馬來酸/式(I-1)/N-環己基馬來醯亞胺/苯乙烯之共聚合物、(甲基)丙烯酸/馬來酸酐/式 (I-1)/N-環己基馬來醯亞胺/苯乙烯之共聚合物、(甲基)丙烯酸/式(I-1)/(甲基)丙烯酸甲基酯/N-環己基馬來醯亞胺/苯乙烯之共聚合物、巴豆酸/式(II-1)/N-環己基馬來醯亞胺/苯乙烯之共聚合物、馬來酸/式(II-1)/N-環己基馬來醯亞胺/苯乙烯之共聚合物、(甲基)丙烯酸/馬來酸酐/式(II-1)/N-環己基馬來醯亞胺/苯乙烯之共聚合物、(甲基)丙烯酸/式(II-1)/(甲基)丙烯酸甲基酯/N-環己基馬來醯亞胺/苯乙烯之共聚合物等。 Specific examples of the resin [K2] include (meth)acrylic acid/copolymer of the formula (I-1)/methyl (meth)acrylate, and (meth)acrylic acid/form (I-2). / (meth)acrylic acid methyl ester copolymer, (meth)acrylic acid / copolymer of formula (I-3) / (meth)acrylic acid methyl ester, (meth)acrylic acid / formula (I Copolymerization of -4)/(meth)acrylic acid methyl ester copolymer, (meth)acrylic acid/(I-5)/(meth)acrylic acid methyl ester , (meth)acrylic acid / copolymer of methyl (I-6) / (meth) acrylate, (meth) acrylate / methyl (I-7) / (meth) acrylate Copolymer, (meth)acrylic acid / copolymer of methyl (I-8) / (meth) acrylate, (meth) acrylate / methyl (I-9) / (meth) acrylate Copolymer of ester, (meth)acrylic acid / copolymer of methyl (I-10) / methyl (meth)acrylate, (meth)acrylic / formula (I-11) / (meth)acrylic acid Copolymer of methyl ester, (meth)acrylic acid / copolymer of methyl (I-12) / methyl (meth)acrylate, (meth) acrylic / formula (I-13) / (methyl a copolymer of methyl acrylate, a copolymer of (meth)acrylic acid / methyl (I-14) / methyl (meth) acrylate, (meth) acrylic / formula (I-15) / ( Copolymer of methyl (meth) acrylate, copolymer of (meth) acrylate / methyl (II-1) / methyl (meth) acrylate, (meth) acrylate / formula (II-2) / (meth)acrylic acid methyl ester copolymer, (meth)acrylic acid / copolymer of formula (II-3) / (meth)acrylic acid methyl ester, (meth)acrylic acid / formula (II- 4) / (methyl) acrylate methyl ester Compound, (meth)acrylic acid / copolymer of methyl (II-5) / methyl (meth)acrylate, (meth)acrylic acid / methyl (II-6) / methyl (meth)acrylate Copolymer, (meth)acrylic acid / copolymer of formula (II-7) / methyl (meth) acrylate, (meth) acrylate / formula (II-8) / (meth) acrylate Copolymer of base ester, (meth)acrylic acid / copolymer of methyl (II-9) / methyl (meth)acrylate, (meth)acrylic acid / formula (II-10) / (methyl) Copolymer of methyl acrylate, (meth)acrylic acid / copolymer of methyl (II-11) / methyl (meth) acrylate, (meth) acrylate / formula (II-12) / (A Co-polymer of methyl acrylate, (meth)acrylic acid / copolymer of methyl (II-13) / methyl (meth) acrylate, (meth) acrylate / formula (II-14) / Copolymer of methyl (meth) acrylate, copolymer of (meth) acrylate / methyl (II-15) / methyl (meth) acrylate, (meth) acrylate / formula (I-1 Copolymer of /(meth)acrylic acid dicyclopentyl ester, (meth)acrylic acid /copolymer of formula (II-1)/dicyclopentyl (meth)acrylate, (meth)acrylic acid /Formula (I-1) / Formula (II-1) / (A a copolymer of dicyclopentyl acrylate, a copolymer of crotonic acid / dicyclopentyl (I-1) / (meth) acrylate, maleic acid / formula (I-1) / ( Copolymer of dicyclopentyl methyl methacrylate, (meth)acrylic acid / maleic anhydride / copolymer of formula (I-1) / dicyclopentyl (meth) acrylate, (methyl) Acrylic acid / copolymer of formula (I-1) / methyl (meth) acrylate / dicyclopentyl (meth) acrylate, crotonic acid / bicyclic ring of formula (II-1) / (meth) acrylate Copolymer of amyl ester, maleic acid / copolymer of formula (II-1) / dicyclopentyl (meth) acrylate, (meth)acrylic acid / maleic anhydride / formula (II-1) /Copolymer of dicyclopentyl (meth) acrylate, (meth)acrylic acid / methyl (II-1) / methyl (meth) acrylate / dicyclopentyl (meth) acrylate Polymer, (meth)acrylic acid / copolymer of phenyl (I-1) / phenyl (meth) acrylate, (meth) acrylate / phenyl (II-1) / (meth) acrylate Copolymer, (meth)acrylic acid / copolymer of formula (I-1) / formula (II-1) / phenyl (meth) acrylate, crotonic acid / formula (I-1) / (A Co-polymer of phenyl acrylate Maleic acid / copolymer of formula (I-1) / phenyl (meth) acrylate, (meth) acrylic acid / maleic anhydride / phenyl ester of formula (I-1) / (meth) acrylate Copolymer, (meth)acrylic acid / copolymer of formula (I-1) / methyl (meth) acrylate / phenyl (meth) acrylate, crotonic acid / formula (II-1) / ( Copolymer of phenyl methacrylate, copolymer of maleic acid / phenyl (II-1) / phenyl (meth) acrylate, (meth) acrylate / maleic anhydride / formula (II- 1) / co-polymer of phenyl (meth) acrylate, (meth) acrylate / copolymer of formula (II-1) / methyl (meth) acrylate / phenyl (meth) acrylate , (meth)acrylic acid / copolymer of formula (I-1) / diethyl maleate, (meth)acrylic acid / copolymer of formula (II-1) / diethyl maleate, ( Methyl)acrylic acid / copolymer of formula (I-1) / formula (II-1) / diethyl maleate, co-polymer of crotonic acid / formula (I-1) / diethyl maleate , maleic acid / copolymer of formula (I-1) / diethyl maleate, (meth)acrylic acid / maleic anhydride / copolymer of formula (I-1) / diethyl maleate , (meth)acrylic acid / methyl (I-1) / (meth) acrylate / Diethyl maleate Copolymer, crotonic acid / copolymer of formula (II-1) / diethyl maleate, maleic acid / copolymer of formula (II-1) / diethyl maleate, (a Acrylic acid/maleic anhydride/copolymer of formula (II-1)/diethyl maleate, (meth)acrylic acid/methyl (II-1)/methyl (meth)acrylate/Malay Copolymer of diethyl acid, (meth)acrylic acid / copolymer of 2-hydroxyethyl (I-1) / (meth) acrylate, (meth) acrylic / formula (II-1) /co-polymer of 2-hydroxyethyl (meth)acrylate, (meth)acrylic acid / of 2-hydroxyethyl (I-1) / (II-1) / 2-hydroxyethyl (meth)acrylate Polymer, crotonic acid / copolymer of 2-hydroxyethyl (I-1) / (meth) acrylate, maleic acid / 2-hydroxyethyl (I-1) / (meth) acrylate Ester copolymer, (meth)acrylic acid/maleic anhydride/copolymer of formula (I-1)/2-hydroxyethyl (meth)acrylate, (meth)acrylic acid/form (I-1 a copolymer of methyl (meth) acrylate / 2-hydroxyethyl (meth) acrylate, crotonic acid / 2-hydroxyethyl (II-1) / (meth) acrylate Polymer, maleic acid / 2-hydroxyl (II-1) / (meth) acrylate Co-polymer of ethyl ethyl ester, (meth)acrylic acid / maleic anhydride / copolymer of formula (II-1) / 2-hydroxyethyl (meth)acrylate, (meth)acrylic acid / II-1)/(meth)acrylic acid methyl ester/co-polymer of 2-hydroxyethyl (meth)acrylate, (meth)acrylic acid/(I-1)/bicyclo[2,2,1 a copolymer of hept-2-ene, (meth)acrylic acid/copolymer of formula (II-1)/bicyclo[2,2,1]hept-2-ene, (meth)acrylic acid/form ( I-1) / formula (II-1) / bicyclo [2, 2, 1] hept-2-ene copolymer, crotonic acid / formula (I-1) / bicyclo [2, 2, 1] g 2-alkenyl copolymer, maleic acid / copolymer of formula (I-1) / bicyclo [2,2,1]hept-2-ene, (meth)acrylic acid / maleic anhydride / formula (I -1)/bicyclo[2,2,1]hept-2-ene copolymer, (meth)acrylic acid/(I-1)/methyl(meth)acrylate/bicyclo[2,2, 1] co-polymer of hept-2-ene, crotonic acid / copolymer of formula (II-1) / bicyclo [2, 2, 1] hept-2-ene, maleic acid / formula (II-1) /bicyclo[2,2,1]hept-2-ene copolymer, (meth)acrylic acid/maleic anhydride/(II-1)/bicyclo[2,2,1]hept-2-ene Copolymer, (meth)acrylic acid / formula (II-1) / (meth) acrylic acid a copolymer of a base ester/bicyclo[2,2,1]hept-2-ene, a (meth)acrylic acid/copolymer of the formula (I-1)/N-cyclohexylmaleimide, (a) Acrylic acid / copolymer of formula (II-1) / N-cyclohexylmaleimide, (meth)acrylic acid / formula (I-1) / formula (II-1) / N-cyclohexyl horse Copolymer of quinone imine, crotonic acid / copolymer of formula (I-1) / N-cyclohexylmaleimide, maleic acid / formula (I-1) / N-cyclohexylmalay Copolymer of quinone imine, (meth)acrylic acid/maleic anhydride/copolymer of formula (I-1)/N-cyclohexylmaleimide, (meth)acrylic acid/form (I-1 / (meth)acrylic acid methyl ester / N-cyclohexyl maleimide copolymer, crotonic acid / copolymer of formula (II-1) / N-cyclohexyl maleimide, horse Co-polymer of acid/(II-1)/N-cyclohexylmaleimide, (meth)acrylic acid/maleic anhydride/(II-1)/N-cyclohexylmaleimide Copolymer, (meth)acrylic acid / copolymer of formula (II-1) / methyl (meth) acrylate / N-cyclohexyl maleimide, (meth) acrylate / formula (I -1) / copolymer of styrene, (meth)acrylic acid / copolymer of formula (II-1) / styrene, (Meth)acrylic acid / copolymer of formula (I-1) / formula (II-1) / styrene, crotonic acid / copolymer of formula (I-1) / styrene, maleic acid / formula ( I-1)/copolymer of styrene, (meth)acrylic acid/maleic anhydride/copolymer of formula (I-1)/styrene, (meth)acrylic acid/formula (I-1)/( a copolymer of methyl methacrylate/styrene, a crotonic acid/copolymer of formula (II-1)/styrene, a copolymer of maleic acid/formula (II-1)/styrene, (meth)acrylic acid/maleic anhydride/copolymer of formula (II-1)/styrene, (meth)acrylic acid/complex of formula (II-1)/methyl (meth)acrylate/styrene Polymer, (meth)acrylic acid / copolymer of formula (I-1) / N-cyclohexylmaleimide / styrene, (meth)acrylic acid / formula (II-1) / N-cyclohexyl a copolymer of maleic imine/styrene, a copolymer of (meth)acrylic acid/(I-1)/(II-1)/N-cyclohexylmaleimide/styrene, Crotonic acid/copolymer of formula (I-1)/N-cyclohexylmaleimide/styrene, maleic acid/(I-1)/N-cyclohexylmaleimide/styrene Copolymer, (meth)acrylic acid / maleic anhydride / formula (I-1)/N-cyclohexylmaleimide/styrene copolymer, (meth)acrylic acid/(I-1)/(meth)acrylic acid methyl ester/N-cyclohexyl horse Copolymer of bismuth imine/styrene, crotonic acid / copolymer of formula (II-1) / N-cyclohexylmaleimide / styrene, maleic acid / formula (II-1) / Copolymer of N-cyclohexylmaleimide/styrene, (meth)acrylic acid/maleic anhydride/copolymer of formula (II-1)/N-cyclohexylmaleimide/styrene (meth)acrylic acid / methyl (II-1) / (meth) acrylate / N-cyclohexyl maleimide / styrene copolymer.

樹脂(A)之聚苯乙烯換算重量平均分子量,理想的是3,000至100,000,較理想的是5,000至50,000,更佳的是5,000至20,000,特佳5,000至10,000。樹脂(A)之重量平均分子量在前述之範圍內時,硬化性樹脂組成物的塗布性有變良好之傾向。 The polystyrene-equivalent weight average molecular weight of the resin (A) is desirably 3,000 to 100,000, more preferably 5,000 to 50,000, still more preferably 5,000 to 20,000, particularly preferably 5,000 to 10,000. When the weight average molecular weight of the resin (A) is within the above range, the coatability of the curable resin composition tends to be good.

樹脂(A)之分子量分布[重量平均分子量(Mw)/數平均分子量(Mn)],理想的是1.1至6.0,更佳的是1.2至4.0。分子量分布在前述之範圍內時,所得之硬化膜有耐藥品性變優異之傾向。 The molecular weight distribution [weight average molecular weight (Mw) / number average molecular weight (Mn)] of the resin (A) is desirably from 1.1 to 6.0, more preferably from 1.2 to 4.0. When the molecular weight distribution is within the above range, the obtained cured film tends to have excellent chemical resistance.

樹脂(A)之酸價,理想的是30mg-KOH/g以上及180mg-KOH/g以下,較佳是40mg-KOH/g以上及150mg-KOH/g以下,特佳是50mg-KOH/g以上及135mg-KOH/g以下。 The acid value of the resin (A) is preferably 30 mg-KOH/g or more and 180 mg-KOH/g or less, preferably 40 mg-KOH/g or more and 150 mg-KOH/g or less, and particularly preferably 50 mg-KOH/g. Above and below 135 mg-KOH/g.

在此酸價是測定作為用以中和1g樹脂所必要之氫氧化鉀量(mg)的值,可以使用氫氧化鉀溶液藉由滴定而求得。樹脂(A)之酸價在前述之範圍內時,所得之硬化膜與基板之密著性有變優良之傾向。 Here, the acid value is a value which is measured as the amount (mg) of potassium hydroxide necessary for neutralizing 1 g of the resin, and can be determined by titration using a potassium hydroxide solution. When the acid value of the resin (A) is within the above range, the adhesion between the obtained cured film and the substrate tends to be excellent.

樹脂(A)之含量,相對於本發明之硬化性樹脂組成物的固形分,理想的是30至90質量%,較佳的是35至80質量%,更佳的是40至70質量%。樹脂(A)之含量在前述之範圍內時,所 得到之硬化膜的耐熱性優,且與基板之密著性及耐藥品性有變優良之傾向。在此,硬化性樹脂組成物的固形分是指本發明之硬化性樹脂組成物的總量除去溶劑(E)的含量所剩餘之量稱之。 The content of the resin (A) is preferably from 30 to 90% by mass, preferably from 35 to 80% by mass, more preferably from 40 to 70% by mass, based on the solid content of the curable resin composition of the present invention. When the content of the resin (A) is within the aforementioned range, The cured film obtained is excellent in heat resistance, and has a tendency to be excellent in adhesion to a substrate and chemical resistance. Here, the solid content of the curable resin composition means that the total amount of the curable resin composition of the present invention is the amount remaining in the solvent (E).

〈(甲基)丙烯酸系化合物(B)〉 <(Meth)acrylic compound (B)>

(甲基)丙烯酸系化合物(B)是具有選自丙烯醯基及甲基丙烯醯基所成群組中至少1種之基的化合物。 The (meth)acrylic compound (B) is a compound having at least one selected from the group consisting of an acryloyl group and a methacryl group.

作為具有1個(甲基)丙烯醯基的(甲基)丙烯酸系化合物(B)者,可以列舉與作為前述(a)、(b)及(c)所列舉之化合物相同者,其中,以(甲基)丙烯酸酯類為佳。 Examples of the (meth)acrylic compound (B) having one (meth)acryl fluorenyl group are the same as those exemplified as the above-mentioned (a), (b), and (c). (Meth) acrylates are preferred.

作為具有2個(甲基)丙烯醯基的(甲基)丙烯酸系化合物者,可以列舉:1,3-丁二醇二(甲基)丙烯酸酯、1,3-丁二醇(甲基)丙烯酸酯、1,6-己二醇二(甲基)丙烯酸酯、乙二醇二(甲基)丙烯酸酯、二乙二醇二(甲基)丙烯酸酯、新戊二醇二(甲基)丙烯酸酯、三乙二醇二(甲基)丙烯酸酯、四乙二醇二(甲基)丙烯酸酯、聚乙二醇二丙烯酸酯、雙酚A之雙(丙烯醯氧基乙基)醚、乙氧基化雙酚A二(甲基)丙烯酸酯、丙氧基化新戊二醇二(甲基)丙烯酸酯、乙氧基化新戊二醇二(甲基)丙烯酸酯、3-甲基戊二醇二(甲基)丙烯酸酯等。 Examples of the (meth)acrylic compound having two (meth)acrylonyl groups include 1,3-butanediol di(meth)acrylate and 1,3-butanediol (methyl). Acrylate, 1,6-hexanediol di(meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, neopentyl glycol di(methyl) Acrylate, triethylene glycol di(meth)acrylate, tetraethylene glycol di(meth)acrylate, polyethylene glycol diacrylate, bisphenol A bis(acryloxyethyl)ether, Ethoxylated bisphenol A di(meth) acrylate, propoxylated neopentyl glycol di(meth) acrylate, ethoxylated neopentyl glycol di(meth) acrylate, 3-methyl Pentyl glycol di(meth)acrylate or the like.

作為具有3個(甲基)丙烯醯基的(甲基)丙烯酸系化合物者,可以列舉:三羥甲基丙烷三(甲基)丙烯酸酯、季戊四醇三(甲基)丙烯酸酯、參(2-羥基乙基)異氰酸酯三(甲基)丙烯酸酯、乙氧基化三羥甲基丙烷三(甲基)丙烯酸酯、丙氧基化三羥甲基丙烷三(甲基)丙烯酸酯、季戊四醇四(甲基)丙烯酸酯、二季戊四醇五(甲基)丙烯酸酯、二季戊四醇六(甲基)丙烯酸酯、三季戊四醇四(甲基) 丙烯酸酯、三季戊四醇五(甲基)丙烯酸酯、三季戊四醇六(甲基)丙烯酸酯、三季戊四醇七(甲基)丙烯酸酯、三季戊四醇八(甲基)丙烯酸酯、季戊四醇三(甲基)丙烯酸酯與酸酐之反應物、二季戊四醇五(甲基)丙烯酸酯與酸酐之反應物、三季戊四醇七(甲基)丙烯酸酯與酸酐之反應物、己內酯改質三羥甲基丙烷三(甲基)丙烯酸酯、己內酯改質季戊四醇三(甲基)丙烯酸酯、己內酯改質參(2-羥基乙基)異氰酸酯三(甲基)丙烯酸酯、己內酯改質季戊四醇四(甲基)丙烯酸酯、己內酯改質二季戊四醇五(甲基)丙烯酸酯、己內酯改質二季戊四醇六(甲基)丙烯酸酯、己內酯改質三季戊四醇四(甲基)丙烯酸酯、己內酯改質三季戊四醇五(甲基)丙烯酸酯、己內酯改質三季戊四醇六(甲基)丙烯酸酯、己內酯改質三季戊四醇七(甲基)丙烯酸酯、己內酯改質三季戊四醇八(甲基)丙烯酸酯、己內酯改質季戊四醇三(甲基)丙烯酸酯與酸酐之反應物、己內酯改質二季戊四醇五(甲基)丙烯酸酯與酸酐之反應物、己內酯改質三季戊四醇七(甲基)丙烯酸酯與酸酐之反應物等。 Examples of the (meth)acrylic compound having three (meth)acrylinyl groups include trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, and ginseng (2- Hydroxyethyl)isocyanate tri(meth)acrylate, ethoxylated trimethylolpropane tri(meth)acrylate, propoxylated trimethylolpropane tri(meth)acrylate, pentaerythritol tetra ( Methyl) acrylate, dipentaerythritol penta (meth) acrylate, dipentaerythritol hexa (meth) acrylate, tripentaerythritol tetra (methyl) Acrylate, tripentaerythritol penta (meth) acrylate, tripentaerythritol hexa (meth) acrylate, tripentaerythritol hepta (meth) acrylate, tripentaerythritol octa (meth) acrylate, pentaerythritol tri (meth) acrylate Reaction of an ester with an acid anhydride, a reaction of dipentaerythritol penta (meth) acrylate with an acid anhydride, a reaction of a tripentaerythritol hepta (meth) acrylate with an acid anhydride, and a caprolactone modified trimethylolpropane tris (a Acrylate, caprolactone modified pentaerythritol tri(meth) acrylate, caprolactone modified ginseng (2-hydroxyethyl) isocyanate tri(meth) acrylate, caprolactone modified pentaerythritol tetra (a) Acrylate, caprolactone modified dipentaerythritol penta (meth) acrylate, caprolactone modified dipentaerythritol hexa (meth) acrylate, caprolactone modified tripentaerythritol tetra (meth) acrylate, Caprolactone modified tripentaerythritol penta (meth) acrylate, caprolactone modified trimellititol hexa(meth) acrylate, caprolactone modified tripellitate pentoxide (meth) acrylate, caprolactone modification Tripentaerythritol octa (meth) acrylate, caprolactone Reacting a reaction of pentaerythritol tri(meth) acrylate with an acid anhydride, a reaction of caprolactone-modified dipentaerythritol penta (meth) acrylate with an acid anhydride, and caprolactone-modified trimellititol seven (meth) acrylate A reactant with an acid anhydride or the like.

作為(甲基)丙烯酸系化合物(B)者,以具有3個以上(甲基)丙烯醯基的(甲基)丙烯酸系化合物為佳,以二季戊四醇六(甲基)丙烯酸酯為更佳。 As the (meth)acrylic compound (B), a (meth)acrylic compound having three or more (meth)acrylonyl groups is preferred, and dipentaerythritol hexa(meth)acrylate is more preferred.

本發明的硬化性樹脂組成物含有(甲基)丙烯酸系化合物(B)的情形,其之含量,相對於樹脂(A)之含量100質量份,理想的是20至100質量份,更佳的是25至70質量份。(甲基)丙烯酸系化合物(B)的含量在上述範圍內時,得到之硬化膜的耐藥品性及機械強度有變良好之傾向。 In the case where the curable resin composition of the present invention contains the (meth)acrylic compound (B), the content thereof is preferably 20 to 100 parts by mass, more preferably 100 parts by mass based on the content of the resin (A). It is 25 to 70 parts by mass. When the content of the (meth)acrylic compound (B) is within the above range, the chemical resistance and mechanical strength of the cured film obtained tend to be improved.

〈環氧樹脂(C)〉 <Epoxy Resin (C)>

環氧樹脂(C),除了是有與樹脂(A)不同的結構之外,並無特別之限定,以有選自縮水甘油基醚型環氧樹脂及縮水甘油基酯型環氧樹脂所成群組中至少1種為理想。 The epoxy resin (C) is not particularly limited as long as it has a structure different from that of the resin (A), and is selected from the group consisting of a glycidyl ether type epoxy resin and a glycidyl ester type epoxy resin. At least one of the groups is ideal.

縮水甘油基醚型環氧樹脂是有縮水甘油基醚結構之環氧樹脂,可以藉由酚類或多元醇等與環氧氯丙烷反應而合成。 The glycidyl ether type epoxy resin is an epoxy resin having a glycidyl ether structure and can be synthesized by reacting with a phenol or a polyhydric alcohol or the like.

作為縮水甘油基醚型環氧樹脂者,例如,可以列舉:雙酚A型環氧樹脂、雙酚F型環氧樹脂、聯苯型環氧樹脂、酚酚醛型環氧樹脂、o-甲酚酚醛型環氧樹脂及參羥基苯基甲烷型環氧樹脂。 Examples of the glycidyl ether type epoxy resin include bisphenol A type epoxy resin, bisphenol F type epoxy resin, biphenyl type epoxy resin, phenol novolak type epoxy resin, and o-cresol. Phenolic epoxy resin and parahydroxyphenylmethane epoxy resin.

縮水甘油基酯型環氧樹脂是有縮水甘油基酯結構之環氧樹脂,可以藉由苯二甲酸衍生物或脂肪酸等之羰基與環氧氯丙烷反應而合成。 The glycidyl ester type epoxy resin is an epoxy resin having a glycidyl ester structure, and can be synthesized by reacting a carbonyl group such as a phthalic acid derivative or a fatty acid with epichlorohydrin.

作為縮水甘油基酯型環氧樹脂者,例如,可以列舉:由p-羥基安息香酸、m-羥基安息香酸、對苯二甲酸等之芳香族羧酸所衍生之縮水甘油酯型環氧樹脂。 Examples of the glycidyl ester type epoxy resin include a glycidyl ester type epoxy resin derived from an aromatic carboxylic acid such as p-hydroxybenzoic acid, m-hydroxybenzoic acid or terephthalic acid.

本發明的硬化性樹脂組成物中使用的環氧樹脂(C),係以雙酚A型環氧樹脂、雙酚F型環氧樹脂、酚酚醛型環氧樹脂、o-甲酚酚醛型環氧樹脂、聚酚型環氧樹脂等之縮水甘油基醚型環氧樹脂為理想,其中,以雙酚A型環氧樹脂為特佳。 The epoxy resin (C) used in the curable resin composition of the present invention is a bisphenol A type epoxy resin, a bisphenol F type epoxy resin, a phenol novolak type epoxy resin, and an o-cresol novolac type ring. A glycidyl ether type epoxy resin such as an oxygen resin or a polyphenol type epoxy resin is preferable, and among them, a bisphenol A type epoxy resin is particularly preferable.

如上述的縮水甘油醚型環氧樹脂,可以藉由使用以往公知的方法,將對應的酚類與環氧氯丙烷在強鹼的存在下藉由縮合而合成。相關的反應,可以藉由該技術業者以往公知的方法來進行。又,也可以使用市售品。作為雙酚A型環氧樹脂的市售品者,可以列舉:JER157S70、EPICOAT 1001、EPICOAT 1002、 EPICOAT 1003、EPICOAT 1004、EPICOAT 1007、EPICOAT 1009、EPICOAT 1010、EPICOAT 828(三菱化學(股)製)等。作為雙酚F型環氧樹脂的市售品者,可以列舉:EPICOAT 807(三菱化學(股)製)、YDF-170(東都化成(股)製)等。作為酚酚醛型環氧樹脂的市售品者,可以列舉:EPICOAT 152、EPICOAT 154(三菱化學(股)製)、EPPN-201、EPPN-202(日本化藥(股)製)、DEN-438(陶氏化學公司製)等。作為o-甲酚酚醛型環氧樹脂的市售品者,可以列舉:EOCN-125S、EOCN-103S、EOCN-104S、EOCN-1020、EOCN-1025、EOCN-1027(日本化藥(股)製)等。作為聚酚型環氧樹脂的市售品者,可以列舉:EPICOAT 1032H60、EPICOAT YX-4000(三菱化學(股)製)等。 The glycidyl ether type epoxy resin described above can be synthesized by condensation of a corresponding phenol and epichlorohydrin in the presence of a strong base by a conventionally known method. The related reaction can be carried out by a method known to those skilled in the art. Further, a commercially available product can also be used. As a commercial product of bisphenol A type epoxy resin, JER157S70, EPICOAT 1001, EPICOAT 1002 can be cited. EPICOAT 1003, EPICOAT 1004, EPICOAT 1007, EPICOAT 1009, EPICOAT 1010, EPICOAT 828 (manufactured by Mitsubishi Chemical Corporation). The commercially available product of the bisphenol F-type epoxy resin may, for example, be EPICOAT 807 (manufactured by Mitsubishi Chemical Corporation) or YDF-170 (manufactured by Tohto Kasei Co., Ltd.). As a commercial product of the phenol novolak type epoxy resin, EPICOAT 152, EPICOAT 154 (manufactured by Mitsubishi Chemical Corporation), EPPN-201, EPPN-202 (manufactured by Nippon Kayaku Co., Ltd.), DEN-438 (manufactured by The Dow Chemical Company) and the like. As a commercial product of the o-cresol novolac type epoxy resin, EOCN-125S, EOCN-103S, EOCN-104S, EOCN-1020, EOCN-1025, EOCN-1027 (manufactured by Nippon Kayaku Co., Ltd.) can be cited. )Wait. As a commercial item of the polyphenol type epoxy resin, EPICOAT 1032H60, EPICOAT YX-4000 (made by Mitsubishi Chemical Corporation), etc. are mentioned.

環氧樹脂(C)的環氧當量是以100至500g/eq為理想,更佳的是150至400g/eq。在此,環氧當量是由每1個環氧基的環氧樹脂之分子量來定義。環氧當量,例如,可以依JIS K7236所規定的方法來測定。 The epoxy equivalent of the epoxy resin (C) is preferably from 100 to 500 g/eq, more preferably from 150 to 400 g/eq. Here, the epoxy equivalent is defined by the molecular weight of the epoxy resin per one epoxy group. The epoxy equivalent can be measured, for example, according to the method specified in JIS K7236.

環氧樹脂(C)的酸價,通常是未達30mg-KOH/g,以在10mg-KOH/g以下為佳。 The acid value of the epoxy resin (C) is usually less than 30 mg-KOH/g, preferably 10 mg-KOH/g or less.

又,環氧樹脂(C)的重量平均分子量,理想的是300至10,000,較佳的是400至6,000,更佳的是500至4,800。 Further, the weight average molecular weight of the epoxy resin (C) is desirably from 300 to 10,000, preferably from 400 to 6,000, more preferably from 500 to 4,800.

本發明的硬化性樹脂組成物含有環氧樹脂(C)的情形,其之含有量,相對於樹脂(A)與(甲基)丙烯酸系化合物(B)的合計含有量100質量份,理想的是1至60質量份,更佳的是5至50質量份。環氧樹脂(C)之含有量在前述範圍內時,所得之硬化膜與基板之密著性有變優良之傾向。 When the curable resin composition of the present invention contains the epoxy resin (C), the content thereof is preferably 100 parts by mass based on the total content of the resin (A) and the (meth)acrylic compound (B). It is 1 to 60 parts by mass, more preferably 5 to 50 parts by mass. When the content of the epoxy resin (C) is within the above range, the adhesion between the obtained cured film and the substrate tends to be excellent.

〈聚合起始劑(D)〉 <Polymerization initiator (D)>

聚合起始劑(D)是藉由光或熱的作用而產生活性自由基、氧等,只要可以開始聚合的化合物即可,而無特別限定,可以使用公知的聚合起始劑。 The polymerization initiator (D) is a compound which can generate a living radical, oxygen, or the like by light or heat, and is not particularly limited as long as it can start polymerization, and a known polymerization initiator can be used.

作為聚合起始劑(D)者,是以含有選自O-醯基肟化合物、烷基苯酮化合物、三嗪化合物、醯基膦氧化合物及聯咪唑化合物所成群組中至少1種的聚合起始劑為佳,而以含有O-醯基肟化合物的聚合起始劑為更佳。有此等之聚合起始劑時,是高感度,並且在可見光區域中透過率有變高的傾向。 The polymerization initiator (D) is at least one selected from the group consisting of an O-mercaptopurine compound, an alkylphenone compound, a triazine compound, a mercaptophosphine oxide compound, and a biimidazole compound. A polymerization initiator is preferred, and a polymerization initiator containing an O-fluorenyl ruthenium compound is more preferred. When such a polymerization initiator is used, it is highly sensitive, and the transmittance tends to be high in the visible light region.

O-醯基肟化合物是有以式(d1)所示部分結構之化合物。以下,*是表示結合鍵。 The O-mercaptopurine compound is a compound having a partial structure represented by the formula (d1). Hereinafter, * is a binding bond.

作為O-醯基肟化合物者,例如,可以列舉:N-苯甲醯氧基-1-(4-苯基硫基苯基)丁烷-1-酮-2-亞胺、N-苯甲醯氧基-1-(4-苯基硫基苯基)辛烷-1-酮-2-亞胺、N-苯甲醯氧基-1-(4-苯基硫基苯基)-3-環戊基丙烷-1-酮-2-亞胺、N-乙醯氧基-1-[9-乙基-6-(2-甲基苯甲醯基)-9H-咔唑-3-基]乙烷-1-亞胺、N-乙醯氧基-1-[9-乙基-6-{2-甲基-4-(3,3-二甲基-2,4-二氧雜環戊基甲基氧基)苯甲醯基}-9H-咔唑-3-基]乙烷-1-亞胺、N-乙醯氧基-1-[9-乙基-6-(2-甲基苯甲醯基)-9H-咔唑-3-基]-3-環戊基丙烷-1-亞胺、N-苯甲醯氧基-1-[9-乙基-6-(2-甲基苯甲醯基)-9H-咔唑-3-基]-3-環戊基丙烷-1-酮-2-亞胺。也可以使用Irgacure(註冊商標)OXE 01、OXE 02(以上,BASF公司 製)、N-1919(ADEKA公司製)等之市售品。 As the O-mercaptopurine compound, for example, N-benzylideneoxy-1-(4-phenylthiophenyl)butan-1-one-2-imine, N-benzoic acid can be cited.醯oxy-1-(4-phenylthiophenyl)octane-1-one-2-imine, N-benzylideneoxy-1-(4-phenylthiophenyl)-3 -cyclopentylpropan-1-one-2-imine, N-acetoxy-1-[9-ethyl-6-(2-methylbenzylidene)-9H-indazole-3- Ethyl-1-imine, N-acetoxy-1-[9-ethyl-6-{2-methyl-4-(3,3-dimethyl-2,4-dioxo Heterocyclic amylmethyloxy)benzhydryl}-9H-indazol-3-yl]ethane-1-imine, N-ethyloxy-1-[9-ethyl-6-( 2-methylbenzimidyl)-9H-indazol-3-yl]-3-cyclopentylpropane-1-imine, N-benzylideneoxy-1-[9-ethyl-6- (2-Methylbenzylidene)-9H-indazol-3-yl]-3-cyclopentylpropan-1-one-2-imine. Irgacure (registered trademark) OXE 01, OXE 02 (above, BASF) A product such as N-1919 (made by Adeka Co., Ltd.).

烷基苯酮化合物是有以式(d2)所示部分結構或是式(d3)所示部分結構之化合物。此等之部分結構中,苯環也可以有取代基。 The alkylphenone compound is a compound having a partial structure represented by the formula (d2) or a partial structure represented by the formula (d3). In some of these structures, the benzene ring may have a substituent.

作為有以式(d2)所示部分結構之化合物者,可以列舉:2-甲基-2-N-嗎啉基-1-(4-甲基硫基苯基)丙烷-1-酮、2-二甲基胺基-1-(4-N-嗎啉基苯基)-2-苄基丁烷-1-酮、2-(二甲基胺基)-2-[(4-甲基苯基)甲基]-1-[4-(4-嗎啉基)苯基]丁烷-1-酮。也可以使用Irgacure(註冊商標)369、907及379(以上,BASF公司製)等之市售品。又,在日本特表2002-544205號公報中所載,也可以使用有引起鏈移動之基的聚合起始劑。 As a compound having a partial structure represented by the formula (d2), 2-methyl-2-N-morpholinyl-1-(4-methylthiophenyl)propan-1-one, 2 -Dimethylamino-1-(4-N-morpholinylphenyl)-2-benzylbutan-1-one, 2-(dimethylamino)-2-[(4-methyl) Phenyl)methyl]-1-[4-(4-morpholinyl)phenyl]butan-1-one. Commercial products such as Irgacure (registered trademark) 369, 907, and 379 (above, manufactured by BASF Corporation) can also be used. Further, as disclosed in Japanese Laid-Open Patent Publication No. 2002-544205, a polymerization initiator having a group which causes chain movement can also be used.

作為有以式(d3)所示部分結構之化合物者,可以列舉:2-羥基-2-甲基-1-苯基丙烷-1-酮、2-羥基-2-甲基-1-[4-(2-羥基乙氧基)苯基]丙烷-1-酮、1-羥基環己基苯基酮、2-羥基-2-甲基-1-(4-異丙烯基苯基)丙烷-1-酮之寡聚合物、α,α-二乙氧基苯乙酮及苄基二甲基縮酮。 As a compound having a partial structure represented by the formula (d3), 2-hydroxy-2-methyl-1-phenylpropan-1-one, 2-hydroxy-2-methyl-1-[4] -(2-hydroxyethoxy)phenyl]propan-1-one, 1-hydroxycyclohexyl phenyl ketone, 2-hydroxy-2-methyl-1-(4-isopropenylphenyl)propane-1 a ketone oligomer, α,α-diethoxyacetophenone and benzyldimethylketal.

從感度之觀點,作為烷基苯酮化合物者,以有式(d2)所示的部分結構化合物為佳。 From the viewpoint of sensitivity, as the alkylphenone compound, a partially structural compound represented by the formula (d2) is preferred.

作為三嗪化合物者,例如,可以列舉:2,4-雙(三氯甲基)-6-(4-甲氧基苯基)-1,3,5-三嗪、2,4-雙(三氯甲基)-6-(4-甲氧基萘基)-1,3,5-三嗪、2,4-雙(三氯甲基)-6-楜椒基-1,3,5-三嗪、2,4-雙(三 氯甲基)-6-(4-甲氧基苯乙烯基)-1,3,5-三嗪、2,4-雙(三氯甲基)-6-[2-(5-甲基呋喃-2-基)乙烯基-1, 3,5-三嗪、2,4-雙(三氯甲基)-6-[2-(呋喃-2-基)乙烯基]-1,3,5-三嗪、2,4-雙(三氯甲基)-6-[2-(4-二乙基胺基-2-甲基苯基)乙烯基]-1,3,5-三嗪及2,4-雙(三氯甲基)-6-[2-(3,4-二甲氧基苯基)乙烯基]-1,3,5-三嗪。 As the triazine compound, for example, 2,4-bis(trichloromethyl)-6-(4-methoxyphenyl)-1,3,5-triazine, 2,4-bis ( Trichloromethyl)-6-(4-methoxynaphthyl)-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-anthraquinone-1,3,5 - triazine, 2,4-double (three Chloromethyl)-6-(4-methoxystyryl)-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-[2-(5-methylfuran) -2-yl)vinyl-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-[2-(furan-2-yl)vinyl]-1,3,5 Triazine, 2,4-bis(trichloromethyl)-6-[2-(4-diethylamino-2-methylphenyl)vinyl]-1,3,5-triazine and 2,4-bis(trichloromethyl)-6-[2-(3,4-dimethoxyphenyl)vinyl]-1,3,5-triazine.

作為醯基膦氧化合物者,可列舉2,4,6-三甲基苯甲醯基二苯基膦氧化合物等。也可以使用Irgacure 819(汽巴日本公司製)等之市售品。 Examples of the mercaptophosphine compound include 2,4,6-trimethylbenzimidyldiphenylphosphine oxide and the like. Commercial products such as Irgacure 819 (manufactured by Ciba Japan Co., Ltd.) can also be used.

作為聯咪唑化合物者,例如,可列舉:2,2’-雙(2-氯苯基)-4,4',5,5'-四苯基聯咪唑、2,2'-雙(2,3-二氯苯基)-4,4',5,5'-四苯基聯咪唑(例如,參照JPH06-75372-A、JPH06-75373-A等。)、2,2'-雙(2-氯苯基)-4,4',5,5'-四苯基聯咪唑、2,2'-雙(2-氯苯基)-4,4',5,5'-四(烷氧基苯基)聯咪唑、2,2'-雙(2-氯苯基)-4,4',5,5'-四(二烷氧基苯基)聯咪唑、2,2'-雙(2-氯苯基)-4,4',5,5'-四(三烷氧基苯基)聯咪唑(例如,參照JPS48-38403-B、JPS62-174204-A等。)、4,4',5,5'-位之苯基為藉由碳烷氧基所取代之聯咪唑化合物(例如,參照JPH07-10913-A等)。 As the biimidazole compound, for example, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenylbiimidazole, 2,2'-bis (2, 3-dichlorophenyl)-4,4',5,5'-tetraphenylbiimidazole (for example, refer to JPH06-75372-A, JPH06-75373-A, etc.), 2,2'-double (2 -Chlorophenyl)-4,4',5,5'-tetraphenylbiimidazole, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetra(alkoxy) Phenyl)biimidazole, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetrakis(dialkoxyphenyl)biimidazole, 2,2'-bis ( 2-chlorophenyl)-4,4',5,5'-tetrakis(trialkoxyphenyl)biimidazole (for example, refer to JPS48-38403-B, JPS62-174204-A, etc.), 4, 4 The phenyl group at the ', 5, 5'-position is a biimidazole compound substituted with a carbamoyloxy group (for example, refer to JPH07-10913-A, etc.).

又,作為聚合起始劑(D)者,可以列舉:苯偶因、苯偶因甲基醚、苯偶因乙基醚、苯偶因丙基醚、苯偶因異丁基醚等之苯偶因化合物;二苯甲酮、o-苯甲醯基安息香酸甲酯、4-苯基二苯甲酮、4-苯甲醯基-4'-甲基二苯基硫化物、3,3',4,4'-四(三級-丁基過氧化物羰基)二苯甲酮、2,4,6-三甲基二苯甲酮等二苯甲酮化物;9,10-菲醌、2-乙基蒽醌、樟腦醌等醌化合物;10-丁基-2-氯吖啶酮、苯偶醯、苯基乙醛酸甲酯、二茂鈦化合物等。此等是 以與後述之聚合起始助劑(D1)(尤其胺類)組合使用為佳。 Further, examples of the polymerization initiator (D) include benzene, benzoin methyl ether, benzoin ethyl ether, benzoin propyl ether, and benzoin isobutyl ether. Occasion compound; benzophenone, methyl o-benzylidene benzoate, 4-phenylbenzophenone, 4-benzylidene-4'-methyldiphenyl sulfide, 3,3 ',4,4'-tetrakis (tertiary-butyl peroxide carbonyl) benzophenone, 2,4,6-trimethylbenzophenone and other benzophenones; 9,10-phenanthrenequinone An anthraquinone compound such as 2-ethylhydrazine or camphorquinone; 10-butyl-2-chloroacridone, benzophenone, methyl phenylglyoxylate, and a titanocene compound. These are It is preferably used in combination with a polymerization starting aid (D1) (especially an amine) to be described later.

作為聚合起始劑(D)者,氧產生劑也可以使用。 As the polymerization initiator (D), an oxygen generating agent can also be used.

作為氧產生劑者,例如,可以列舉:4-羥基苯基二甲基鋶p-甲苯磺酸鹽、4-羥基苯基二甲基鋶六氟銻酸鹽、4-乙醯氧基苯基二甲基鋶p-甲苯磺酸鹽、4-乙醯氧基苯基.甲基.苯甲醯鋶六氟銻酸鹽、三苯基鋶p-甲苯磺酸鹽、三苯基鋶六氟銻酸鹽、二苯基錪p-甲苯磺酸鹽、二苯基錪六氟銻酸鹽等鎓鹽類,或硝基苄基甲苯磺酸酯類(tosylate)、苯偶因甲苯磺酸酯類。 Examples of the oxygen generator include 4-hydroxyphenyldimethylpyridinium-p-toluenesulfonate, 4-hydroxyphenyldimethylsulfonium hexafluoroantimonate, and 4-ethyloxyphenylene. Dimethyl 鋶 p-toluene sulfonate, 4-ethyl methoxy phenyl. methyl. Benzoe hexafluoroantimonate, triphenylsulfonium p-toluenesulfonate, triphenylsulfonium hexafluoroantimonate, diphenylphosphonium p-toluenesulfonate, diphenylphosphonium hexafluoroantimonate a salt such as a salt, or a nitrobenzyl tosylate or a benzoin tosylate.

本發明的硬化性樹脂組成物含有聚合起始劑(D)的情形,其之含有量,相對於樹脂(A)與(甲基)丙烯酸系化合物(B)的合計含有量100質量份,理想的是0.1至30質量份,較佳的是0.5至15質量份,更佳的是1至8質量份。聚合起始劑(D)之含有量在前述範圍內時,由於高感度化曝光時間有縮短之傾向,故生產性提高,再者所得之圖案的可見光透過率有變高的傾向。 When the curable resin composition of the present invention contains the polymerization initiator (D), the content thereof is preferably 100 parts by mass based on the total content of the resin (A) and the (meth)acrylic compound (B). It is 0.1 to 30 parts by mass, preferably 0.5 to 15 parts by mass, more preferably 1 to 8 parts by mass. When the content of the polymerization initiator (D) is within the above range, the high-sensitivity exposure time tends to be shortened, so that the productivity is improved, and the visible light transmittance of the obtained pattern tends to be high.

〈聚合起始助劑(D1)〉 <Polymerization starter (D1)>

聚合起始助劑(D1)是與聚合起始劑(D)同時使用,用以促進藉由聚合起始劑(D)開始聚合之聚合性化合物(例如,(甲基)丙烯酸系化合物(B))之聚合的化合物,或是增感劑。 The polymerization initiation aid (D1) is used together with the polymerization initiator (D) to promote a polymerizable compound (for example, a (meth)acrylic compound (B) which starts polymerization by the polymerization initiator (D). )) a polymerized compound, or a sensitizer.

作為聚合起始劑(D1)者,可以列舉:噻唑啉化合物、胺化合物、烷氧基蒽化合物、噻噸酮化合物、羧酸化合物等。 Examples of the polymerization initiator (D1) include a thiazoline compound, an amine compound, an alkoxy fluorene compound, a thioxanthone compound, and a carboxylic acid compound.

作為噻唑啉化合物者,可以列舉式(III-1)至式(III-3)所示化合物,JP2008-65319-A記載之化合物等。 Examples of the thiazoline compound include a compound represented by the formula (III-1) to the formula (III-3), a compound described in JP2008-65319-A, and the like.

作為胺化合物者,可以列舉:三乙醇胺、甲基二乙醇胺、三異丙醇胺、4-二甲基胺基安息香酸甲酯、4-二甲基胺基安息香酸乙酯、4-二甲基胺基安息香酸異戊酯、安息香酸2-二甲基胺基乙酯、4-二甲基胺基安息香酸2-乙基己酯、N,N-二甲基對甲苯胺、4,4'-雙(二甲基胺基)二苯甲酮(通稱米希勒酮)、4,4'-雙(二乙基胺基)二苯甲酮、4,4'-雙(乙基甲基胺基)二苯甲酮等,其中,以4,4'-雙(二乙基胺基)二苯甲酮為佳。也可以使用EAB-F(保土谷化學工業(股)製)等之市售品。 As the amine compound, there may be mentioned: triethanolamine, methyldiethanolamine, triisopropanolamine, methyl 4-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, 4-dimethyl Isoamyl benzoic acid benzoate, 2-dimethylaminoethyl benzoate, 2-ethylhexyl 4-dimethylaminobenzoate, N,N-dimethyl-p-toluidine, 4, 4'-bis(dimethylamino)benzophenone (commonly known as Michlerone), 4,4'-bis(diethylamino)benzophenone, 4,4'-bis(ethyl Methylamino)benzophenone or the like is preferred, and 4,4'-bis(diethylamino)benzophenone is preferred. Commercial products such as EAB-F (manufactured by Hodogaya Chemical Industry Co., Ltd.) can also be used.

作為烷基蒽化合物者,可以列舉:9,10-二甲氧基蒽、2-乙基-9,10-二甲氧基蒽、9,10-二乙氧基蒽、2-乙基-9,10-二乙氧基蒽、9,10-二丁氧基蒽、2-乙基-9,10-二丁氧基蒽等。 As the alkyl hydrazine compound, there may be mentioned: 9,10-dimethoxyanthracene, 2-ethyl-9,10-dimethoxyanthracene, 9,10-diethoxyanthracene, 2-ethyl- 9,10-diethoxyanthracene, 9,10-dibutoxyanthracene, 2-ethyl-9,10-dibutoxyanthracene, and the like.

作為噻噸酮化合物者,可以列舉:2-異丙基噻噸酮、4-異丙基噻噸酮、2,4-二乙基噻噸酮、2,4-二氯噻噸酮、1-氯-4-丙氧基噻噸酮等。 As the thioxanthone compound, 2-isopropylthioxanthone, 4-isopropylthioxanthone, 2,4-diethylthioxanthone, 2,4-dichlorothioxanthone, 1 -Chloro-4-propoxythioxanthone and the like.

作為羧酸化合物者,可以列舉:苯基硫基醋酸、甲基苯基硫基醋酸、乙基苯基硫基醋酸、甲基乙基苯基硫基醋酸、 二甲基苯基硫基醋酸、甲氧基苯基硫基醋酸、二甲氧基苯基硫基醋酸、氯苯基硫基醋酸、二氯苯基硫基醋酸、N-苯基甘胺酸、苯氧基醋酸、萘基硫代醋酸、N-萘基甘胺酸、萘氧基醋酸等。 Examples of the carboxylic acid compound include phenylthioacetic acid, methylphenylthioacetic acid, ethylphenylthioacetic acid, and methylethylphenylthioacetic acid. Dimethylphenylthioacetic acid, methoxyphenylthioacetic acid, dimethoxyphenylthioacetic acid, chlorophenylthioacetic acid, dichlorophenylthioacetic acid, N-phenylglycine , phenoxyacetic acid, naphthylthioacetic acid, N-naphthylglycine, naphthyloxyacetic acid, and the like.

本發明的硬化性樹脂組成物含有聚合起始助劑(D1)的情形,其之含有量,相對於樹脂(A)與(甲基)丙烯酸系化合物(B)的合計含有量100質量份,理想的是0.1至30質量份,更佳的是0.2至10質量份。聚合起始助劑(D1)之含有量在前述範圍內時,形成圖案之際,有變得高感度的傾向。 In the case where the curable resin composition of the present invention contains the polymerization initiation aid (D1), the content thereof is 100 parts by mass based on the total content of the resin (A) and the (meth)acrylic compound (B). It is preferably 0.1 to 30 parts by mass, more preferably 0.2 to 10 parts by mass. When the content of the polymerization initiation aid (D1) is within the above range, the pattern tends to be highly sensitive when the pattern is formed.

〈硫醇化合物(T)〉 <thiol compound (T)>

硫醇化合物(T)是在分子內有巰基(-SH)之化合物。其中,係以有2個以上巰基之化合物為佳,以有2個以上與脂肪族烴結構的碳原子結合之巰基的化合物為更佳。硫醇化合物(T)是以與聚合起始劑(D)共同使用為佳。 The thiol compound (T) is a compound having a mercapto group (-SH) in the molecule. Among them, a compound having two or more mercapto groups is preferred, and a compound having two or more mercapto groups bonded to a carbon atom of an aliphatic hydrocarbon structure is more preferred. The thiol compound (T) is preferably used together with the polymerization initiator (D).

作為硫醇化合物(T)者,例如可以列舉:己烷二硫醇、癸烷二硫醇、1,4-雙(甲基巰基)苯、丁二醇雙(3-巰基丙酸酯)、丁二醇雙(3-巰基乙酸酯)、乙二醇雙(3-巰基乙酸酯)、三羥甲基丙烷參(3-巰基乙酸酯)、丁二醇雙(3-巰基丙酸酯)、三羥甲基丙烷參(3-巰基丙酸酯)、三羥甲基丙烷參(3-巰基乙酸酯)、季戊四醇肆(3-巰基丙酸酯)、季戊四醇肆(3-巰基乙酸酯)、參羥基乙基參(3-巰基乙酸酯)、季戊四醇肆(3-巰基丁酸酯)、及1,4-雙(3-巰基丁氧基)丁烷。 Examples of the thiol compound (T) include hexane dithiol, decane dithiol, 1,4-bis(methylindenyl)benzene, butanediol bis(3-mercaptopropionate), and Butanediol bis(3-mercaptoacetate), ethylene glycol bis(3-mercaptoacetate), trimethylolpropane ginseng (3-mercaptoacetate), butanediol bis(3-mercaptopropane) Acid ester), trimethylolpropane ginseng (3-mercaptopropionate), trimethylolpropane ginseng (3-mercaptoacetate), pentaerythritol bismuth (3-mercaptopropionate), pentaerythritol bismuth (3- Mercaptoacetate), hydroxyethyl ginseng (3-mercaptoacetate), pentaerythritol ruthenium (3-mercaptobutyrate), and 1,4-bis(3-mercaptobutoxy)butane.

本發明的硬化性樹脂組成物含有硫醇化合物(T)的情形,其之含有量,相對於聚合起始劑(D)的含有量100質量份,理想的是10至90質量份,更佳的是15至70質量份。硫醇化合 物(T)之含有量在前述範圍內時,感度變高,又顯影性有變良好的傾向。 In the case where the curable resin composition of the present invention contains the thiol compound (T), the content thereof is preferably 10 to 90 parts by mass, more preferably 100 parts by mass, based on 100 parts by mass of the polymerization initiator (D). It is 15 to 70 parts by mass. Thiol combination When the content of the substance (T) is within the above range, the sensitivity is high and the developability tends to be good.

〈抗氧化劑(F)〉 <Antioxidant (F)>

作為抗氧化劑(F)者,可以列舉:酚系抗氧化劑、硫系抗氧化劑、磷系抗氧化劑、胺系抗氧化劑。其中,從硬化膜的著色少的觀點而言,以酚系抗氧化劑為佳。 Examples of the antioxidant (F) include a phenol-based antioxidant, a sulfur-based antioxidant, a phosphorus-based antioxidant, and an amine-based antioxidant. Among them, a phenolic antioxidant is preferred from the viewpoint of less coloration of the cured film.

作為酚系抗氧化劑者,例如,可以列舉:丙烯酸2-三級丁基-6-(3-三級丁基-2-羥基-5-甲基苄基)-4-甲基苯基酯、丙烯酸2-[1-(2-羥基-3,5-二-三級-戊基苯基)乙基]-4,6-二-三級丁基苯基酯、3,9-雙[2-{3-(3-三級-丁基-4-羥基-5-甲基苯基)丙烯氧基}-1,1-二甲基乙基]-2,4,8,10-四氧雜螺[5,5]十一烷、2,2'-亞甲基雙(6-三級丁基-4-甲基酚)、4,4'-亞丁基雙(6-三級丁基-3-甲基酚)、4,4'-硫基雙(2-三級丁基-5-甲基酚)、2,2'-硫基雙(6-三級丁基-4-甲基酚)、1,3,5-參(3,5-二-三級丁基-4-羥基苄基)-1,3,5-三嗪-2,4,6(1H,3H,5H)三酮、3,3',3",5,5',5"-六-三級丁基-a,a',a"-(均三甲苯基-2,4,6-三基)三-p-甲酚、季戊四醇肆[3-(3,5-二-三級丁基-4-羥基苯基)丙酸酯]、2,6-二-三級丁基-4-甲基酚及6-[3-(3-三級丁基-4-羥基-5-甲基苯基)丙氧基]-2,4,8,10-四-三級丁基-二苯并[d,f]{1,3,2}二氧雜磷雜環庚烷。 Examples of the phenolic antioxidant include 2-tributylbutyl-6-(3-tert-butyl-2-hydroxy-5-methylbenzyl)-4-methylphenyl acrylate. 2-[1-(2-hydroxy-3,5-di-tri-pentylphenyl)ethyl]-4,6-di-tert-butylphenyl acrylate, 3,9-bis[2] -{3-(3-Tris-butyl-4-hydroxy-5-methylphenyl)propenyloxy}-1,1-dimethylethyl]-2,4,8,10-tetraoxy Heterospiro[5,5]undecane, 2,2'-methylenebis(6-tributyl-4-methylphenol), 4,4'-butylene bis(6-tertiary butyl) -3-methylphenol), 4,4'-thiobis(2-tert-butyl-5-methylphenol), 2,2'-thiobis(6-tris-butyl-4-methyl) Phenol), 1,3,5-gin (3,5-di-tri-butyl-4-hydroxybenzyl)-1,3,5-triazine-2,4,6(1H,3H,5H Triketone, 3,3',3",5,5',5"-hexa-tertiary butyl-a,a',a"-(mesityl-2,4,6-triyl) Tri-p-cresol, pentaerythritol bismuth [3-(3,5-di-tri-butyl-4-hydroxyphenyl)propionate], 2,6-di-tributyl-4-methyl Phenol and 6-[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propoxy]-2,4,8,10-tetra-tertiary butyl-dibenzo[ d, f] {1, 3, 2} dioxaphospholane.

作為前述酚系抗氧化劑者,也可以使用市售品,作為市售的酚系抗氧化劑者,例如,可以列舉:SUMILIZER(註冊商標)BHT、GM、GS、GP(以上全是住友化學(股)製)、Irganox(註冊商標)1010、1076、1330、3114(以上全是BASF公司製)。 As a phenolic antioxidant, a commercially available product may be used, and as a commercially available phenolic antioxidant, for example, SUMILIZER (registered trademark) BHT, GM, GS, and GP (all of which are Sumitomo Chemical Co., Ltd.) )), Irganox (registered trademark) 1010, 1076, 1330, 3114 (all of which are manufactured by BASF Corporation).

作為硫系抗氧化劑者,例如,可以列舉:3,3'-硫基 二丙酸二月桂基酯、3,3'-硫基二丙酸二肉豆蔻基酯、3,3'-硫基二丙酸二硬脂醯基酯、及季戊四醇肆(3-月桂基硫基丙酸酯)。作為前述硫系抗氧化劑者,也可以使用市售品,作為市售的硫系抗氧化劑者,例如,可以列舉:SUMILIZER(註冊商標)TPL-R、TP-D(以上全是住友化學(股)製)。 As a sulfur-based antioxidant, for example, a 3,3'-thio group can be cited. Dilauryl dipropionate, dimyristyl 3,3'-thiodipropionate, distearyl 3,3'-thiodipropionate, and barium pentaerythritol (3-lauryl sulfur) Propionate). As a sulfur-based antioxidant, a commercially available product may be used, and as a commercially available sulfur-based antioxidant, for example, SUMILIZER (registered trademark) TPL-R, TP-D (all of which are Sumitomo Chemical Co., Ltd.) )system).

作為磷系抗氧化劑者,例如,可以列舉:磷酸三辛基酯、磷酸三(十二烷基)酯、磷酸三癸基酯、磷酸參(壬基苯基)酯、二硬脂醯基季戊四醇二磷酸酯、及四(三癸基)-1,1,3-參(2-甲基-5-三級丁基-4-羥基苯基)丁烷二磷酸酯。作為前述磷系抗氧化劑者,也可以使用市售品,作為市售的磷系抗氧化劑者,例如,可以列舉:IRGAFOS(註冊商標)168、12、38(以上,全是BASF公司製)、ADK STAB 329K及ADK STAB PE36(以上,全是ADEKA製)。 Examples of the phosphorus-based antioxidant include trioctyl phosphate, tris(dodecyl) phosphate, tridecyl phosphate, decylphenyl phosphate, and distearyl pentylenetetraol. Diphosphate, and tetrakis(trimethyl)-1,1,3-glycol(2-methyl-5-tributyl-4-hydroxyphenyl)butane diphosphate. As a phosphorus-based antioxidant, a commercially available product may be used, and as a commercially available phosphorus-based antioxidant, for example, IRGAFOS (registered trademark) 168, 12, and 38 (all of which are manufactured by BASF Corporation) may be mentioned. ADK STAB 329K and ADK STAB PE36 (all above, all made by ADEKA).

作為胺系抗氧化劑者,例如,可以列舉:N,N'-二-二級丁基-p-伸苯二胺、N,N'-二-異丙基-p-伸苯二胺、N,N'-二-環己基-p-伸苯二胺、N,N'-二-苯基-p-伸苯二胺、及N,N'-雙(2-萘基)-p-伸苯二胺。作為前述胺系抗氧化劑者,也可以使用市售品,作為市售的胺系抗氧化劑者,例如,可以列舉:SUMILIZER(註冊商標)BPA、BPA-M1、4ML(以上,全是住友化學(股)製)。 Examples of the amine-based antioxidant include N,N'-di-secondary butyl-p-phenylenediamine, N,N'-di-isopropyl-p-phenylenediamine, and N. , N'-di-cyclohexyl-p-phenylenediamine, N,N'-di-phenyl-p-phenylenediamine, and N,N'-bis(2-naphthyl)-p-stretch Phenylenediamine. As the above-mentioned amine-based antioxidant, a commercial product may be used, and as a commercially available amine-based antioxidant, for example, SUMILIZER (registered trademark) BPA, BPA-M1, and 4ML (above, all of Sumitomo Chemical ( Stock system)).

本發明的硬化性樹脂組成物含有抗氧化劑(F)的情形,其之含有量,相對於樹脂(A)與(甲基)丙烯酸系化合物(B)的合計含有量100質量份,理想的是0.1質量份以上及5質量份以下,更佳的是0.5質量份以上及3質量份以下。抗氧化劑(F)之含有量在前述範圍內時,所得之硬化膜的耐熱性及鉛筆硬度有變優良的傾向。 When the curable resin composition of the present invention contains the antioxidant (F), the content thereof is preferably 100 parts by mass based on the total content of the resin (A) and the (meth)acrylic compound (B). 0.1 parts by mass or more and 5 parts by mass or less, more preferably 0.5 parts by mass or more and 3 parts by mass or less. When the content of the antioxidant (F) is within the above range, the heat resistance and pencil hardness of the obtained cured film tend to be excellent.

〈界面活性劑(H)〉 <Interacting Agent (H)>

作為界面活性劑(H)者,可以列舉:矽氧系界面活性劑、氟系界面活性劑、有含氟原子之矽氧系界面活性劑等。 Examples of the surfactant (H) include a ruthenium-based surfactant, a fluorine-based surfactant, and a ruthenium-based surfactant having a fluorine atom.

作為矽氧系界面活性劑者,可以列舉:有矽氧烷結合之界面活性劑。 As the oxime-based surfactant, a surfactant having a siloxane coupling is exemplified.

具體的,可以列舉:Toray Silicone DC3PA、Toray Silicone SH7PA、Toray Silicone DC11PA、Toray Silicone SH21PA、Toray Silicone SH28PA、Toray Silicone SH29PA、Toray Silicone SH30PA、聚醚改質矽油SH8400(商品名;Toray Dow Corning(股)製)、KP321、KP322、KP323、KP324、KP326、KP340、KP341(信越化學工業(股)製)、TSF400、TSF401、TSF410、TSF4300、TSF 4440、TSF4445、TSF-4446、TSF4452、TSF4460(Momentive Performance Materials日本合同公司製)等。 Specifically, Toray Silicone DC3PA, Toray Silicone SH7PA, Toray Silicone DC11PA, Toray Silicone SH21PA, Toray Silicone SH28PA, Toray Silicone SH29PA, Toray Silicone SH30PA, Polyether Modified Emu Oil SH8400 (trade name; Toray Dow Corning) System), KP321, KP322, KP323, KP324, KP326, KP340, KP341 (Shin-Etsu Chemical Co., Ltd.), TSF400, TSF401, TSF410, TSF4300, TSF 4440, TSF4445, TSF-4446, TSF4452, TSF4460 (Momentive Performance Materials) Japanese contract company system) and so on.

作為含氟系界面活性劑者,可以列舉有氟碳鏈之界面活性劑。 As a fluorine-containing surfactant, a surfactant of a fluorocarbon chain is mentioned.

具體的,可以列舉:Fluorinert(註冊商標)FC430、Fluorinert FC 431(住友3M(股)製)、MEGAFAC(註冊商標)F142D、MEGAFAC F171、MEGAFAC F172、MEGAFAC F173、MEGAFAC F177、MEGAFAC F183、MEGAFAC F552、MEGAFAC F553、MEGAFAC F554、MEGAFAC F555、MEGAFAC F556、MEGAFAC F558、MEGAFAC F559、MEGAFAC R30(DIC(股)製)、FTOP(註冊商標)EF301、FTOP EF303、FTOP EF351、FTOP EF352(三菱材料電子化成(股)製)、SURFLON(註冊商標)S381、SURFLON S382、SURFLON SC101、SURFLON SC105(旭硝子(股)製)、E5844(Daikin fine chemical 研究所製(股)製)等。 Specific examples include Fluorinert (registered trademark) FC430, Fluorinert FC 431 (manufactured by Sumitomo 3M Co., Ltd.), MEGAFAC (registered trademark) F142D, MEGAFAC F171, MEGAFAC F172, MEGAFAC F173, MEGAFAC F177, MEGAFAC F183, and MEGAFAC F552. MEGAFAC F553, MEGAFAC F554, MEGAFAC F555, MEGAFAC F556, MEGAFAC F558, MEGAFAC F559, MEGAFAC R30 (made by DIC), FTOP (registered trademark) EF301, FTOP EF303, FTOP EF351, FTOP EF352 (Mitsubishi Materials Electronics Co., Ltd. )), SURFLON (registered trademark) S381, SURFLON S382, SURFLON SC101, SURFLON SC105 (made by Asahi Glass Co., Ltd.), E5844 (Daikin fine chemical) Research institute system (share) system, etc.

作為有氟原子之矽氧系界面活性劑者,可以列舉有矽氧烷結合及氟碳鏈之界面活性劑,具體的,可以列舉:MEGAFAC(註冊商標)R08、MEGAFAC BL20、MEGAFAC F475、MEGAFAC F477、MEGAFAC F443(DIC(股)製)等。理想的,可以列舉MEGAFAC(註冊商標)F475。 Examples of the oxime-based surfactant having a fluorine atom include a surfactant of a siloxane coupling and a fluorocarbon chain, and specific examples thereof include MEGAFAC (registered trademark) R08, MEGAFAC BL20, MEGAFAC F475, and MEGAFAC F477. , MEGAFAC F443 (DIC (share) system) and so on. Ideally, MEGAFAC (registered trademark) F475 can be cited.

本發明的硬化性樹脂組成物含有界面活性劑(H)的情形,其之含有量,相對於本發明的硬化性樹脂組成物的總量是0.001質量%以上及0.2質量%以下,理想的是0.002質量%以上及0.1質量%以下,更佳的是0.01質量%以上及0.05質量%以下。界面活性劑(H)之含有量在前述範圍內時,所得之硬化膜的平坦性可以提高。 When the curable resin composition of the present invention contains the surfactant (H), the content thereof is preferably 0.001% by mass or more and 0.2% by mass or less based on the total amount of the curable resin composition of the present invention. 0.002% by mass or more and 0.1% by mass or less, more preferably 0.01% by mass or more and 0.05% by mass or less. When the content of the surfactant (H) is within the above range, the flatness of the obtained cured film can be improved.

〈多價羧酸(G)〉 <polyvalent carboxylic acid (G)>

多價羧酸(G)是選自多價羧酸酐及多價羧酸所成群組中至少1種的化合物。多價羧酸是指有2個以上之羧基的化合物,多價羧酸酐是指多價羧酸的無水物。多價羧酸(G)是以有分子量3000以下為佳,以有分子量1000以下為更佳。 The polyvalent carboxylic acid (G) is a compound selected from the group consisting of a polyvalent carboxylic anhydride and a polyvalent carboxylic acid. The polyvalent carboxylic acid means a compound having two or more carboxyl groups, and the polyvalent carboxylic anhydride means an anhydrous substance of a polyvalent carboxylic acid. The polyvalent carboxylic acid (G) is preferably a molecular weight of 3,000 or less, more preferably 1,000 or less.

作為前述之多價羧酸酐者,例如,可以列舉:馬來酸酐、琥珀酸酐、戊二酸酐、檸康酸酐、衣康酸酐、2-十二烷基琥珀酸酐、2-(2-辛-3-烯基)琥珀酸酐、2-(2,4,6-三甲基壬-3-烯基)琥珀酸酐、三胺甲萘(tricarbary)酸酐、1,2,3,4-丁烷四羧酸二酐等鏈狀多價羧酸酐;3,4,5,6-四氫苯二甲酸酐、1,2,3,6-四氫苯二甲酸酐、二甲基四氫苯二甲酸酐、六氫苯二甲酸酐、4-甲基六氫苯二甲酸 酐、降冰片烯二羧酸酐、甲基雙環[2,2,1]庚烷-2,3-二羧酸酐、雙環[2,2,1]庚烷-2,3-二羧酸酐、雙環[2,2,1]庚-5-烯-2,3-二羧酸酐、甲基雙環[2,2,1]庚-5-烯-2,3-二羧酸酐、環戊烷四羧酸二酐等脂環式多價羧酸酐;苯二甲酸酐、3-乙烯基苯二甲酸酐、4-乙烯基苯二甲酸酐、均苯四甲酸酐、偏苯三酸酐、二苯甲酮四羧酸二酐、3,3',4,4'-二苯基磺基四羧酸二酐、乙二醇雙(脫水偏苯三酸酯)、甘油參(脫水偏苯三酸酯)、甘油雙(脫水偏苯三酸酯)單乙酸酯、1,3,3a,4,5,9b-六氫-5-(四氫-2,5-二氧雜-3-呋喃基)萘并[1,2,-c]呋喃-1,3-二酮等芳香族多價羧酸酐;等。 Examples of the polyvalent carboxylic acid anhydride include maleic anhydride, succinic anhydride, glutaric anhydride, citraconic anhydride, itaconic anhydride, 2-dodecylsuccinic anhydride, and 2-(2-oct-3). -alkenyl)succinic anhydride, 2-(2,4,6-trimethylindol-3-enyl) succinic anhydride, tricarbary anhydride, 1,2,3,4-butane tetracarboxylate Chain polyvalent carboxylic anhydride such as acid dianhydride; 3,4,5,6-tetrahydrophthalic anhydride, 1,2,3,6-tetrahydrophthalic anhydride, dimethyltetrahydrophthalic anhydride , hexahydrophthalic anhydride, 4-methylhexahydrophthalic acid Anhydride, norbornene dicarboxylic anhydride, methyl bicyclo[2,2,1]heptane-2,3-dicarboxylic anhydride, bicyclo[2,2,1]heptane-2,3-dicarboxylic anhydride, bicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride, methylbicyclo[2,2,1]hept-5-ene-2,3-dicarboxylic anhydride, cyclopentane tetracarboxylate An alicyclic polyvalent carboxylic anhydride such as acid dianhydride; phthalic anhydride, 3-vinyl phthalic anhydride, 4-vinyl phthalic anhydride, pyromellitic anhydride, trimellitic anhydride, benzophenone tetracarboxylic acid Desic anhydride, 3,3',4,4'-diphenylsulfotetracarboxylic dianhydride, ethylene glycol bis(hydrogen trimellitate), glycerol (dehydrated trimellitate), glycerin double (dehydrated trimellitate) monoacetate, 1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxa-3-furanyl)naphtho[ 1,2,-c] an aromatic polyvalent carboxylic anhydride such as furan-1,3-dione;

也可以使用:Adeka Hardner EH-700(商品名(以下相同)、ADEKA(股)製)、Rikacid-HH、Rikacid-TH、Rikacid-MH、Rikacid MH-700(新日本理化(股)製)、Epicure 126、Epicure YH-306、Epicure DX-126(油化SHELL EOPXY(股)製)等之市售品。 It is also possible to use: Adeka Hardner EH-700 (trade name (same as below), ADEKA Co., Ltd.), Rikacid-HH, Rikacid-TH, Rikacid-MH, Rikacid MH-700 (Nippon Chemical and Chemical Co., Ltd.), Commercial products such as Epicure 126, Epicure YH-306, and Epicure DX-126 (oiled SHELL EOPXY).

作為前述多價羧酸者,可以列舉:草酸、丙二酸、己二酸、癸二酸、富馬酸、酒石酸、檸檬酸、導出鏈狀多價羧酸酐之多價羧酸等鏈狀多價羧酸;環己烷二羧酸、導出脂環式多價羧酸酐之多價羧酸等脂環式多價羧酸;間苯二甲酸、對苯二甲酸、1,4,5,8-萘四羧酸、導出芳香族多價羧酸酐之多價羧酸的芳香族多價羧酸;等。 Examples of the polyvalent carboxylic acid include chain-like polyoxalates such as oxalic acid, malonic acid, adipic acid, sebacic acid, fumaric acid, tartaric acid, citric acid, and a chain-like polyvalent carboxylic acid anhydride. a carboxylic acid; a cyclohexane dicarboxylic acid; an alicyclic polyvalent carboxylic acid such as a polyvalent carboxylic acid derived from an alicyclic polyvalent carboxylic anhydride; isophthalic acid, terephthalic acid, 1, 4, 5, 8 - naphthalenetetracarboxylic acid, an aromatic polyvalent carboxylic acid derived from a polyvalent carboxylic acid of an aromatic polyvalent carboxylic anhydride;

其中,從硬化膜之耐熱性優,尤其是在可見光區域的透明性不易下降之觀點而言,以鏈狀羧酸酐、脂環式多價羧酸酐為佳,以脂環式多價羧酸酐為更佳。 Among them, from the viewpoint of excellent heat resistance of the cured film, particularly in view of the fact that the transparency in the visible light region is not easily lowered, chain carboxylic anhydride and alicyclic polyvalent carboxylic anhydride are preferred, and alicyclic polyvalent carboxylic anhydride is used. Better.

本發明的硬化性樹脂組成物含有多價羧酸(G)的情形,其之含有量,相對於樹脂(A)與(甲基)丙烯酸系化合物(B)的合計含有量100質量份,理想的是1質量份至30質量份,較佳的是2質量份至20質量份,更佳的是2質量份至15質量份。多價羧酸(G)之含有量在前述範圍內時,所得之硬化膜的耐熱性及密著性優。 When the curable resin composition of the present invention contains a polyvalent carboxylic acid (G), the content thereof is preferably 100 parts by mass based on the total content of the resin (A) and the (meth)acrylic compound (B). It is 1 part by mass to 30 parts by mass, preferably 2 parts by mass to 20 parts by mass, more preferably 2 parts by mass to 15 parts by mass. When the content of the polyvalent carboxylic acid (G) is within the above range, the obtained cured film is excellent in heat resistance and adhesion.

〈咪唑化合物(J)〉 <Imidazole compound (J)>

咪唑化合物(J),只要是有咪唑骨幹之化合物即可,而無特別限定,例如,可以列舉己知的作為環氧硬化劑之化合物。其中,是以式(2)所示的化合物為佳。 The imidazole compound (J) is not particularly limited as long as it is a compound having an imidazole backbone, and examples thereof include known compounds which are known as epoxy curing agents. Among them, a compound represented by the formula (2) is preferred.

[式(2)中,R11是表示碳數1至20的烷基、苯基、苄基或是碳數2至5之氰基烷基。R12至R14是互相獨立,表示氫原子、鹵原子、碳數1至20之烷基、苯基、硝基或是碳數1至20之醯基,該烷基及該苯基中所含之氫原子,也可以被羥基取代。] [In the formula (2), R 11 represents an alkyl group having 1 to 20 carbon atoms, a phenyl group, a benzyl group or a cyanoalkyl group having 2 to 5 carbon atoms. R 12 to R 14 are independently of each other and represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 20 carbon atoms, a phenyl group, a nitro group or a fluorenyl group having 1 to 20 carbon atoms, and the alkyl group and the phenyl group The hydrogen atom contained may also be substituted by a hydroxyl group. ]

作為碳數1至20之烷基者,例如,可以列舉:甲基、乙基、丙基、異丁基、丁基、三級丁基、己基、庚基、辛基、壬基、癸基、十七烷基及十一烷基。 Examples of the alkyl group having 1 to 20 carbon atoms include a methyl group, an ethyl group, a propyl group, an isobutyl group, a butyl group, a tertiary butyl group, a hexyl group, a heptyl group, an octyl group, a decyl group, and a decyl group. , heptadecyl and undecyl.

作為碳數2至5之氰基烷基者,例如,可以列舉:氰基甲基、氰基乙基、氰基丙基、氰基丁基及氰基戊基。 As the cyanoalkyl group having 2 to 5 carbon atoms, for example, a cyanomethyl group, a cyanoethyl group, a cyanopropyl group, a cyanobutyl group, and a cyanopentyl group can be exemplified.

作為鹵原子者,例如,可以列舉:氟原子、氯原子 及溴原子。 As the halogen atom, for example, a fluorine atom or a chlorine atom can be cited. And bromine atoms.

作為碳數1至20的醯基者,例如,可以列舉:甲醯基、乙醯基、丙醯基、異丁醯基、戊醯基、異戊醯基、三甲基乙醯基、月桂醯基、肉豆蔻醯基及硬脂醯基。 Examples of the fluorenyl group having 1 to 20 carbon atoms include a fluorenyl group, an ethyl fluorenyl group, a propyl fluorenyl group, an isobutyl fluorenyl group, a pentamidine group, an isovaleryl group, a trimethyl acetyl group, and a lauryl group. , nutmeg and stearin.

作為咪唑化合物(J)者,例如,可以列舉:1-甲基咪唑、2-甲基咪唑、2-羥基甲基咪唑、2-甲基-4-羥基甲基咪唑、5-羥基甲基-4-甲基咪唑、2-乙基咪唑、2-十一烷基咪唑、2-十七烷基咪唑、1,2-二甲基咪唑、2-乙基-4-甲基咪唑、4-羥基甲基-2-苯基咪唑、2-苯基咪唑、2-苯基2-羥基甲基咪唑、1-苄基-4-甲基咪唑、1-苄基-4-甲基咪唑、1-苄基-4-苯基咪唑、1-苄基-5-羥基甲基咪唑、2-(p-羥基苯基)咪唑、1-氰基甲基-2-甲基咪唑、1-(2-氰基乙基)-2-羥基甲基咪唑、2,4-二苯基咪唑、1-氰基甲基-2-十一烷基咪唑、1-氰基甲基-2-乙基-4-甲基咪唑、1-氰基甲基-2-苯基咪唑及1-(2-氰基乙基)-2-乙基-4-甲基咪唑。其中,以1-苄基-4-苯基咪唑、2-乙基-4-甲基咪唑及1-(2-氰基乙基)-2-乙基-4-甲基咪唑為佳。 As the imidazole compound (J), for example, 1-methylimidazole, 2-methylimidazole, 2-hydroxymethylimidazole, 2-methyl-4-hydroxymethylimidazole, 5-hydroxymethyl- 4-methylimidazole, 2-ethylimidazole, 2-undecylimidazole, 2-heptadecylimidazole, 1,2-dimethylimidazole, 2-ethyl-4-methylimidazole, 4- Hydroxymethyl-2-phenylimidazole, 2-phenylimidazole, 2-phenyl-2-hydroxymethylimidazole, 1-benzyl-4-methylimidazole, 1-benzyl-4-methylimidazole, 1 -benzyl-4-phenylimidazole, 1-benzyl-5-hydroxymethylimidazole, 2-(p-hydroxyphenyl)imidazole, 1-cyanomethyl-2-methylimidazole, 1-(2 -cyanoethyl)-2-hydroxymethylimidazole, 2,4-diphenylimidazole, 1-cyanomethyl-2-undecylimidazole, 1-cyanomethyl-2-ethyl- 4-methylimidazole, 1-cyanomethyl-2-phenylimidazole and 1-(2-cyanoethyl)-2-ethyl-4-methylimidazole. Among them, 1-benzyl-4-phenylimidazole, 2-ethyl-4-methylimidazole and 1-(2-cyanoethyl)-2-ethyl-4-methylimidazole are preferred.

本發明的硬化性樹脂組成物含有咪唑化合物(J)的情形,其之含有量,相對於樹脂(A)與(甲基)丙烯酸系化合物(B)的合計含有量100質量份,理想的是0.1質量份以上及25質量份以下,較佳的是0.2質量份以上及15質量份以下,更佳的是0.5質量份以上及5質量份以下。咪唑化合物(J)之含有量在前述範圍內時,所得之硬化膜在可見光區域中透明性有優異之傾向。 In the case where the curable resin composition of the present invention contains the imidazole compound (J), the content thereof is preferably 100 parts by mass based on the total content of the resin (A) and the (meth)acrylic compound (B). 0.1 parts by mass or more and 25 parts by mass or less, preferably 0.2 parts by mass or more and 15 parts by mass or less, more preferably 0.5 parts by mass or more and 5 parts by mass or less. When the content of the imidazole compound (J) is within the above range, the obtained cured film tends to be excellent in transparency in the visible light region.

〈溶劑(E)〉 <Solvent (E)>

溶劑(E)是含有二烷二醇二烷基醚,與溶劑(E1),與溶劑(E2)。 The solvent (E) is a dialkyl glycol dialkyl ether, and a solvent (E1) and a solvent (E2).

二烷二醇二烷基醚是包含式(E')所示化合物的溶劑。 The dialkyl glycol dialkyl ether is a solvent comprising a compound represented by the formula (E').

[式(E')中,Re1是表示碳數1至3的烷二基。 [In the formula (E'), R e1 is an alkanediyl group having 1 to 3 carbon atoms.

Re2及Re3是互相獨立,表示碳數1至4的烷基。] R e2 and R e3 are independent of each other and represent an alkyl group having 1 to 4 carbon atoms. ]

作為Re1的烷二基者,可以列舉:亞甲基、伸乙基、丙烷-1,2-二基、丙烷-1,3-二基等,而以伸乙基或是丙烷-1,2-二基為佳。 Examples of the alkanediyl group of R e1 include a methylene group, an ethylidene group, a propane-1,2-diyl group, a propane-1,3-diyl group, and the like, and an ethyl group or a propane-1 is used. 2-diyl is preferred.

作為Re2及Re3的烷基者,可以列舉:甲基、乙基、丙基、異丙基、丁基、異丁基。理想的是甲基及乙基。 Examples of the alkyl group of R e2 and R e3 include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, and an isobutyl group. Desirably, methyl and ethyl are preferred.

作為二烷二醇二烷基醚者,可以列舉:二乙二醇二甲基醚、二乙二醇二乙基醚、二乙二醇乙基甲基醚、二乙二醇二丙基醚、二乙二醇二丁基醚等二乙二醇二烷基醚;二丙二醇二甲基醚及二丙二醇二乙基醚等二丙二醇二烷基醚;等。 Examples of the dialkyl glycol dialkyl ether include diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol ethyl methyl ether, and diethylene glycol dipropyl ether. And diethylene glycol dialkyl ether such as diethylene glycol dibutyl ether; dipropylene glycol dialkyl ether such as dipropylene glycol dimethyl ether and dipropylene glycol diethyl ether; and the like.

其中,二烷二醇二烷基醚是以二乙二醇二烷基醚為佳,二乙二醇二甲基醚及二乙二醇乙基甲基醚為較佳,以二乙二醇乙基甲基醚為更佳。 Among them, the dialkyl glycol dialkyl ether is preferably diethylene glycol dialkyl ether, diethylene glycol dimethyl ether and diethylene glycol ethyl methyl ether are preferred, and diethylene glycol is used. Ethyl methyl ether is more preferred.

溶劑(E1)是與二烷二醇二烷基醚不同,並且蒸發速度是將醋酸丁酯的蒸發速度當作100時,為40以上及100以下的溶劑。溶劑(E1)的蒸發速度,理想的是在45以上及未達80,較佳的是50以上及未達75。 The solvent (E1) is different from the dialkyl glycol dialkyl ether, and the evaporation rate is a solvent of 40 or more and 100 or less when the evaporation rate of butyl acetate is 100. The evaporation rate of the solvent (E1) is desirably 45 or more and less than 80, preferably 50 or more and less than 75.

本說明書中,蒸發速度是所謂在單位時間中由單位面積氣化之溶劑的蒸發速度。蒸發速度是表示在溫度23℃、相對 濕度50%中,相對於醋酸n-丁酯的蒸發速度(100),試料(溶劑)的蒸發速度之比率。具體的,測定之方法,係在可能供給氮氣之抽氣櫃(hood)內,設置化學天秤、及放入2號濾紙(70mm ψ)之70mm ψ盤2個,一邊是醋酸n-丁酯,另一邊是試料,分別放入1.0g,抽氣櫃內,以30NL/ml的流速供給氮氣,醋酸n-丁酯及試料的重量是每經過60秒鐘同時測定的方法,將由經過60秒鐘、120秒鐘、180秒鐘的重量算出蒸發速度的平均值當作試料的蒸發速度。 In the present specification, the evaporation rate is a so-called evaporation rate of a solvent which is vaporized per unit area per unit time. The evaporation rate is expressed at a temperature of 23 ° C, relative The ratio of the evaporation rate of the sample (solvent) to the evaporation rate (100) of n-butyl acetate in 50% humidity. Specifically, the method of measuring is to set up a chemical scale and a 70 mm disk placed in No. 2 filter paper (70 mm ,) in a hood that may supply nitrogen gas, and one side is n-butyl acetate. On the other hand, the sample was placed in 1.0 g, and the inside of the extraction cabinet was supplied with nitrogen at a flow rate of 30 NL/ml. The weight of n-butyl acetate and the sample was measured simultaneously every 60 seconds, and 60 seconds passed. The average of the evaporation rates was calculated from the weight of 120 seconds and 180 seconds as the evaporation rate of the sample.

作為溶劑(E1)者,可以列舉:乙二醇單甲基醚(蒸發速度:47)、丙二醇單甲基醚(蒸發速度:62)、丙二醇單乙基醚(蒸發速度:46)等醚溶劑;丙酮酸甲酯(蒸發速度:42)、丙酸甲酯(蒸發速度:45)等酯溶劑;2-丁酮(蒸發速度:40)等酮溶劑;二甲苯(蒸發速度:70)等芳香族烴溶劑;1-丁醇(蒸發速度:47)、2-丁醇(蒸發速度:89)、異丁醇(蒸發速度:74)等醇溶劑;等。 Examples of the solvent (E1) include ether solvents such as ethylene glycol monomethyl ether (evaporation rate: 47), propylene glycol monomethyl ether (evaporation rate: 62), and propylene glycol monoethyl ether (evaporation rate: 46). ; an ester solvent such as methyl pyruvate (evaporation rate: 42), methyl propionate (evaporation rate: 45); a ketone solvent such as 2-butanone (evaporation rate: 40); aroma such as xylene (evaporation rate: 70) A hydrocarbon solvent; an alcohol solvent such as 1-butanol (evaporation rate: 47), 2-butanol (evaporation rate: 89), isobutanol (evaporation rate: 74), and the like.

其中,溶劑(E1)是以丙二醇單甲基醚及乙二醇單甲基醚為佳,以丙二醇單甲基醚為更佳。 Among them, the solvent (E1) is preferably propylene glycol monomethyl ether or ethylene glycol monomethyl ether, and more preferably propylene glycol monomethyl ether.

溶劑(E2)是與二烷二醇二烷基醚不同,並且蒸發速度是將醋酸丁酯的蒸發速度當作100時,為13以上及未達40的溶劑。溶劑(E2)的蒸發速度,理想的是在25以上及未達40,更佳的是30以上及未達40。 The solvent (E2) is different from the dialkyl glycol dialkyl ether, and the evaporation rate is a solvent having 13 or more and less than 40 when the evaporation rate of butyl acetate is taken as 100. The evaporation rate of the solvent (E2) is desirably 25 or more and less than 40, more preferably 30 or more and less than 40.

作為溶劑(E2)者,可以列舉:乙二醇單乙基醚(蒸發速度:32)、乙二醇單丙基醚(蒸發速度:20)、乙二醇單丁基醚(蒸 發速度:19)、丙二醇單丙基醚(蒸發速度:21)等醚溶劑;乳酸甲酯(蒸發速度:29)、乳酸乙酯(蒸發速度:22)、丙酮酸乙酯(蒸發速度:31)等酯溶劑;醋酸3-甲氧基丁基酯(蒸發速度:14)、丙二醇單甲基醚醋酸酯(蒸發速度:33)、丙二醇單乙基醚醋酸酯(蒸發速度:19)、丙二醇單乙基醚丙酸酯(蒸發速度:19)、乙二醇單甲基醚醋酸酯(蒸發速度:31)、乙二醇單乙基醚醋酸酯(蒸發速度:21)、3-甲氧基丙酸甲酯(蒸發速度:32)等醚酯溶劑;4-羥基-4-甲基-2-戊酮(蒸發速度:15)、二異丁酮(蒸發速度:20)、環己酮(蒸發速度:23)等酮溶劑;N,N-二甲基甲醯胺(蒸發速度:17)等醯胺溶劑。 As the solvent (E2), ethylene glycol monoethyl ether (evaporation rate: 32), ethylene glycol monopropyl ether (evaporation rate: 20), ethylene glycol monobutyl ether (steaming) Hair speed: 19), propylene glycol monopropyl ether (evaporation rate: 21) and other ether solvents; methyl lactate (evaporation rate: 29), ethyl lactate (evaporation rate: 22), ethyl pyruvate (evaporation rate: 31 Ester solvent; 3-methoxybutyl acetate (evaporation rate: 14), propylene glycol monomethyl ether acetate (evaporation rate: 33), propylene glycol monoethyl ether acetate (evaporation rate: 19), propylene glycol Monoethyl ether propionate (evaporation rate: 19), ethylene glycol monomethyl ether acetate (evaporation rate: 31), ethylene glycol monoethyl ether acetate (evaporation rate: 21), 3-methoxy Ether ester solvent such as methyl propyl propionate (evaporation rate: 32); 4-hydroxy-4-methyl-2-pentanone (evaporation rate: 15), diisobutyl ketone (evaporation rate: 20), cyclohexanone A ketone solvent such as (evaporation rate: 23); a guanamine solvent such as N,N-dimethylformamide (evaporation rate: 17).

其中,溶劑(E2)是以丙二醇單甲基醚醋酸酯、乙二醇單乙基醚及3-甲氧基丙酸甲酯為佳,以丙二醇單甲基醚醋酸酯為更佳。 Among them, the solvent (E2) is preferably propylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether or methyl 3-methoxypropionate, and more preferably propylene glycol monomethyl ether acetate.

溶劑(E)中各溶劑的含量,相對於溶劑(E)的總量,分別是二烷二醇二烷基醚:1至45質量%溶劑(E1):5至80質量%溶劑(E2):5至80質量%為佳,以二烷二醇二烷基醚:10至40質量%溶劑(E1):10至70質量%溶劑(E2):10至70質量%為更佳。 The content of each solvent in the solvent (E) is dialkyl glycol dialkyl ether, respectively, relative to the total amount of the solvent (E): 1 to 45 mass% solvent (E1): 5 to 80 mass% solvent (E2) 5 to 80% by mass, preferably dialkyl glycol dialkyl ether: 10 to 40% by mass of the solvent (E1): 10 to 70% by mass of the solvent (E2): more preferably 10 to 70% by mass.

混合溶劑的溶劑(E)之蒸發速度,理想的是55以上及90以下,較佳的是55以上及85以下,更佳的是55以上及80以下。 The evaporation rate of the solvent (E) of the mixed solvent is preferably 55 or more and 90 or less, preferably 55 or more and 85 or less, more preferably 55 or more and 80 or less.

溶劑(E)之蒸發速度是可以用上述方法測定。溶劑(E)之蒸發速度在前述範圍內時,減壓乾燥之際的乾燥時間短,尤其,將硬化性樹脂組成物塗布可以得到高的膜平坦性。 The evaporation rate of the solvent (E) can be measured by the above method. When the evaporation rate of the solvent (E) is within the above range, the drying time at the time of drying under reduced pressure is short, and in particular, coating of the curable resin composition can provide high film flatness.

溶劑(E)的含量,相對於本發明的硬化性樹脂組成物的總量,理想的是60至95質量%,較佳的是70至95質量%。換言之,本發明的硬化性樹脂組成物之固形分,理想的是5至40質量%,較佳的是5至30質量%。溶劑(E)之含有量在前述範圍內時,塗布硬化性樹脂組成物得到之膜有平坦性高之傾向。 The content of the solvent (E) is preferably 60 to 95% by mass, preferably 70 to 95% by mass based on the total amount of the curable resin composition of the present invention. In other words, the solid content of the curable resin composition of the present invention is desirably 5 to 40% by mass, preferably 5 to 30% by mass. When the content of the solvent (E) is within the above range, the film obtained by applying the curable resin composition tends to have high flatness.

〈其他的成分〉 <Other ingredients>

在本發明的硬化性樹脂組成物中,因應必要,也可以含有充填劑、其他的高分子化合物、熱自由基產生劑、紫外線吸收劑、鏈移動劑、密著促進劑等,在該領域業界中習知的添加劑。 In the curable resin composition of the present invention, if necessary, a filler, another polymer compound, a thermal radical generator, an ultraviolet absorber, a chain shifting agent, an adhesion promoter, etc. may be contained in the field. A conventional additive.

作為充填劑者,可以列舉:玻璃、二氧化矽、氧化鋁等。 Examples of the filler include glass, cerium oxide, and aluminum oxide.

作為其他的高分子化合物者,可以列舉:馬來醯亞胺樹脂等熱硬化性樹脂及聚乙烯醇、聚丙烯酸、聚乙二醇單烷基醚、聚丙烯酸氟烷基酯、聚酯、聚胺酯等熱可塑性樹脂等。 Examples of other polymer compounds include thermosetting resins such as maleic imine resins, polyvinyl alcohol, polyacrylic acid, polyethylene glycol monoalkyl ether, polyfluoroalkyl acrylate, polyester, and polyurethane. Such as thermoplastic resin.

作為熱自由基產生劑者,可以列舉:2,2'-偶氮雙(2-甲基戊腈)、2,2'-偶氮雙(2,4-二甲基戊腈)等。 Examples of the thermal radical generating agent include 2,2'-azobis(2-methylvaleronitrile) and 2,2'-azobis(2,4-dimethylvaleronitrile).

作為紫外線吸收劑者,可以列舉:2-(3-三級丁基-2- 羥基-5-甲基苯基)-5-氯苯并三唑、烷氧基二苯甲酮等。 As the ultraviolet absorber, it can be mentioned that 2-(3-tert-butyl-2- Hydroxy-5-methylphenyl)-5-chlorobenzotriazole, alkoxybenzophenone and the like.

作為鏈移動劑者,可以列舉:癸烷硫醇、2,4-二苯基-4-甲基-1-戊烯等。 Examples of the chain shifting agent include decanethiol and 2,4-diphenyl-4-methyl-1-pentene.

作為密著促進劑者,可以列舉:乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、乙烯基參(2-甲氧基乙氧基)矽烷、3-縮水甘油氧基丙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基甲基二乙氧基矽烷、2-(3,4-環氧基環己基)乙基三甲氧基矽烷、3-氯丙基甲基二甲氧基矽烷、3-氯丙基三甲氧基矽烷、3-甲基丙烯腈氧基丙基三甲氧基矽烷、3-硫氫基丙基三甲氧基矽烷、3-巰基丙基三甲氧基矽烷、3-三異氰酸酯丙基三乙氧基矽烷、N-2-(胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、N-2-(胺基乙基)-3-胺基丙基甲基二乙氧基矽烷、N-2-(胺基乙基)-3-胺基丙基三甲氧基矽烷、N-2-(胺基乙基)-3-胺基丙基甲基二乙氧基矽烷、3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷等。 Examples of the adhesion promoter include vinyl trimethoxy decane, vinyl triethoxy decane, vinyl ginseng (2-methoxyethoxy) decane, and 3-glycidoxy propyl trimethoxide. Baseline, 3-glycidoxypropylmethyldimethoxydecane, 3-glycidoxypropylmethyldimethoxydecane, 3-glycidoxypropylmethyldiethyl Oxydecane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxydecane, 3-chloropropylmethyldimethoxydecane, 3-chloropropyltrimethoxydecane, 3-methyl Acryloxypropyltrimethoxydecane, 3-sulfhydrylpropyltrimethoxydecane, 3-mercaptopropyltrimethoxydecane, 3-triisocyanatepropyltriethoxydecane, N-2- (Aminoethyl)-3-aminopropylmethyldimethoxydecane, N-2-(aminoethyl)-3-aminopropylmethyldiethoxydecane, N-2- (Aminoethyl)-3-aminopropyltrimethoxydecane, N-2-(aminoethyl)-3-aminopropylmethyldiethoxydecane, 3-aminopropyltrimethyl Oxydecane, 3-aminopropyltriethoxydecane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyl Triethoxy decane and the like.

本發明的硬化性樹脂組成物,實質上沒有含顏料及染料等著色劑。即,本發明的硬化性樹脂組成物中,相對於組成物全體,著色劑的含量,通常是未達1質量%,理想的是未達0.5質量%。 The curable resin composition of the present invention does not substantially contain a coloring agent such as a pigment or a dye. In the curable resin composition of the present invention, the content of the colorant is usually less than 1% by mass, and preferably not more than 0.5% by mass, based on the entire composition.

又,本發明的硬化性樹脂組成物,充填到光路長1cm的石英管中,使用分光光度計,測定波長400至700nm的條件下之透過率之情形,平均透過率,理想的是70%以上,更佳的是80%以上。 Further, the curable resin composition of the present invention is filled in a quartz tube having an optical path length of 1 cm, and a transmittance at a wavelength of 400 to 700 nm is measured using a spectrophotometer, and the average transmittance is preferably 70% or more. More preferably, it is more than 80%.

本發明的硬化性樹脂組成物,在作硬化膜之際,硬化膜的平均透過率理想的是在90%以上,更佳的是95%以上。此平均透過率,對於加熱硬化(100℃至250℃,5分鐘至3小時)後厚度為2μm的硬化膜,使用分光光度計,在波長400至700nm的條件下測定之情形的平均值。藉由此,可以提供在可見光區域透明性優的硬化膜。 In the curable resin composition of the present invention, when the cured film is used, the average transmittance of the cured film is desirably 90% or more, and more preferably 95% or more. This average transmittance is an average value of the case where the cured film having a thickness of 2 μm after heat hardening (100 ° C to 250 ° C, 5 minutes to 3 hours) is measured at a wavelength of 400 to 700 nm using a spectrophotometer. Thereby, it is possible to provide a cured film excellent in transparency in the visible light region.

〈硬化性樹脂組成物的製造方法〉 <Method for Producing Curable Resin Composition>

本發明的硬化性樹脂組成物,是將樹脂(A)及溶劑(E)、以及,因應需要使用的(甲基)丙烯酸系化合物(B),環氧樹脂(C)、聚合起始劑(D)、聚合起始助劑(D1)、抗氧化劑(F)、界面活性劑(H)、多價羧酸(G)、咪唑化合物(J)及其他成分,藉由習知的方法混合而可以製造。混合後,是以孔徑0.05至1.0μm左右的過濾器過濾為理想。 The curable resin composition of the present invention is a resin (A), a solvent (E), and, if necessary, a (meth)acrylic compound (B), an epoxy resin (C), and a polymerization initiator ( D), a polymerization starting aid (D1), an antioxidant (F), a surfactant (H), a polyvalent carboxylic acid (G), an imidazole compound (J) and other ingredients, which are mixed by a conventional method. Can be manufactured. After mixing, it is preferably filtered by a filter having a pore diameter of about 0.05 to 1.0 μm.

〈硬化膜的製造方法〉 <Method for Producing Cured Film>

硬化膜是在基板上塗布本發明的硬化性樹脂組成物,藉由熱使硬化而可以製造。 The cured film can be produced by applying the curable resin composition of the present invention to a substrate and hardening it by heat.

更具體的,本發明的硬化膜的製造方法,是含有以下的步驟(1)至(3)。 More specifically, the method for producing a cured film of the present invention comprises the following steps (1) to (3).

步驟(1)在基板上塗布本發明的硬化性樹脂組成物的步驟。 Step (1) A step of coating the curable resin composition of the present invention on a substrate.

步驟(2)將已塗布的硬化性樹脂組成物減壓乾燥,形成組成物層的步驟。 Step (2) A step of drying the applied curable resin composition under reduced pressure to form a composition layer.

步驟(3)將組成物層加熱的步驟。 Step (3) a step of heating the composition layer.

又,本發明的硬化性樹脂組成物含有聚合起始劑(D) 的情形,藉由進行下述的步驟,可以製造有圖案的硬化膜。 Further, the curable resin composition of the present invention contains a polymerization initiator (D) In the case, a patterned cured film can be produced by performing the following steps.

步驟(1)在基板上塗布本發明的硬化性樹脂組成物的步驟。 Step (1) A step of coating the curable resin composition of the present invention on a substrate.

步驟(2)將已塗布的硬化性樹脂組成物減壓乾燥,形成組成物層的步驟。 Step (2) A step of drying the applied curable resin composition under reduced pressure to form a composition layer.

步驟(2a)將組成物層隔著光罩曝光的步驟。 Step (2a) is a step of exposing the composition layer through a photomask.

步驟(2b)將曝光後的組成物層顯影的步驟。 Step (2b) A step of developing the exposed composition layer.

步驟(3)將顯影後之組成物層加熱的步驟。 Step (3) a step of heating the developed composition layer.

步驟(1)是在基板上塗布本發明的硬化性樹脂組成物的步驟。 The step (1) is a step of applying the curable resin composition of the present invention onto a substrate.

作為基板者,可以列舉:玻璃、金屬、塑膠等,在基板上也可以形成彩色濾光片、絕緣膜、導電膜及/或驅動電路等。 Examples of the substrate include glass, metal, plastic, and the like, and a color filter, an insulating film, a conductive film, and/or a driving circuit may be formed on the substrate.

對基板上塗布,係以使用旋轉塗布機、狹縫及旋轉塗布機、狹縫塗布機、噴墨器、滾筒塗布器、浸漬塗布器等塗布裝置來進行為佳。 The coating on the substrate is preferably carried out using a coating device such as a spin coater, a slit and a spin coater, a slit coater, an inkjet, a roll coater, or a dip coater.

步驟(2)是將已塗布的硬化性樹脂組成物減壓乾燥,形成組成物層的步驟。藉由進行該步驟,除去硬化性樹脂組成物中的溶劑等揮發成分。 The step (2) is a step of drying the applied curable resin composition under reduced pressure to form a composition layer. By performing this step, volatile components such as a solvent in the curable resin composition are removed.

減壓乾燥是以在50至150Pa的壓力下,20至25℃的溫度範圍中進行為佳。 The drying under reduced pressure is preferably carried out at a temperature of from 20 to 25 ° C under a pressure of from 50 to 150 Pa.

在減壓乾燥前或是後,也可以加熱乾燥(預烤)。加熱乾燥通常是使用烘箱、熱盤等之加熱裝置來進行。加熱乾燥的溫度是以30至120℃為佳,50至110℃為更佳。又作為加熱乾燥時間,是以10秒鐘至60分鐘為佳,以30秒鐘至30分鐘為更佳。 It can also be dried by heating (pre-baked) before or after drying under reduced pressure. The heat drying is usually carried out using a heating device such as an oven or a hot plate. The heating and drying temperature is preferably from 30 to 120 ° C, more preferably from 50 to 110 ° C. Further, as the heating and drying time, it is preferably from 10 seconds to 60 minutes, more preferably from 30 seconds to 30 minutes.

步驟(3)是將組成物層加熱的步驟(後烤)。藉由進行加熱而硬化組成物層,形成硬化膜。加熱,通常是使用烘箱、熱盤等之加熱裝置來進行。加熱溫度是以150至250℃為佳,以160至235℃為更佳。加熱時間是以1至120分鐘為佳,以10至60分鐘為更佳。 Step (3) is a step of heating the composition layer (post-baking). The composition layer is hardened by heating to form a cured film. Heating is usually carried out using a heating device such as an oven or a hot plate. The heating temperature is preferably 150 to 250 ° C, more preferably 160 to 235 ° C. The heating time is preferably from 1 to 120 minutes, more preferably from 10 to 60 minutes.

步驟(2a)是藉由步驟(2)所形成的組成物層隔著光罩曝光的步驟。該光罩是對應組成物層之除去部分,使用可以形成遮光部的光罩。遮光部的形成是無特別限定,可以因應目的用途來選擇。 The step (2a) is a step of exposing the composition layer formed by the step (2) through the photomask. The photomask is a removed portion corresponding to the composition layer, and a photomask that can form a light shielding portion is used. The formation of the light shielding portion is not particularly limited and can be selected depending on the intended use.

作為用來曝光的光源,以產生250至450nm波長光的光源為佳。例如,將未達350nm的光,使用切斷此波長區域的濾光器來切割,或是,也可以選擇436nm附近、408nm附近、365nm附近的光,使用取出此等波長區域的帶通濾光片(bandpass filter)。作為光源者,可以列舉:水銀燈、發光二極體、金屬鹵化物燈、鹵素燈等。 As the light source for exposure, a light source for generating light of a wavelength of 250 to 450 nm is preferred. For example, light of less than 350 nm may be cut by using a filter that cuts the wavelength region, or light of a vicinity of 436 nm, around 408 nm, and around 365 nm may be selected, and band pass filtering for taking out such wavelength regions may be used. Bandpass filter. Examples of the light source include a mercury lamp, a light-emitting diode, a metal halide lamp, and a halogen lamp.

或是照射與曝光面全體均勻平行光線,用以可以符合進行光罩與組成物層的正確位置,是以使用光照對準機(mask aligner)、步進器(stepper)等曝光裝置為宜。 Or it is suitable to uniformly align the light with the entire exposed surface to conform to the correct position of the mask and the composition layer, and it is preferable to use an exposure device such as a mask aligner or a stepper.

步驟(2b)將曝光後的組成物層顯影的步驟。將曝光後的組成物層與顯影液接觸,藉由顯影,組成物層的未曝光部會被溶解到顯影液中而除去,在基板上形成有圖案之組成物層。 Step (2b) A step of developing the exposed composition layer. The exposed composition layer is brought into contact with the developer, and by development, the unexposed portion of the composition layer is dissolved in the developer to be removed, and a patterned composition layer is formed on the substrate.

作為顯影液者,是以氫氧化鈣、碳酸氫鈉、碳酸鈉、氫氧化四甲基銨等鹼性化合物的水溶液。此等之鹼性化合物水溶液中之濃度,理想的是0.01至10質量%,更佳的是0.03至5質量 %。再者,也可以含有界面活性劑。 The developer is an aqueous solution of a basic compound such as calcium hydroxide, sodium hydrogencarbonate, sodium carbonate or tetramethylammonium hydroxide. The concentration in the aqueous solution of the basic compound is desirably 0.01 to 10% by mass, more preferably 0.03 to 5% by mass. %. Further, a surfactant may also be contained.

顯影方法,也可以使用攪練法(puddle)、浸漬法(dip)及噴霧法等之任何一種。再者,顯影時基板可以任意角度傾斜。 For the development method, any one of puddle, dip, and spray may be used. Furthermore, the substrate can be tilted at any angle during development.

顯影後,較佳進行水洗。 After development, it is preferably washed with water.

步驟(3a)是將顯影後之組成物層加熱的步驟。與前述步驟(3)同樣操作,藉由加熱來進行,硬化有圖案之組成物層,在基板上形成有圖案之硬化膜。 The step (3a) is a step of heating the developed composition layer. In the same manner as in the above step (3), the patterned composition layer is cured by heating, and a patterned cured film is formed on the substrate.

如此得到之硬化膜,尤其是在乾燥步驟中所要的時間短,並且,由於平坦性優異,例如,可以作為液晶顯示裝置、有機EL顯示裝置或電子紙中使用的彩色濾光片基板、觸控的,保護膜或覆蓋膜使用。藉由此,可能高生產性製造具備有高品質的硬化膜之顯示裝置。 The hardened film thus obtained has a short time in the drying step, and is excellent in flatness, and can be used, for example, as a color filter substrate or a touch panel used in a liquid crystal display device, an organic EL display device, or an electronic paper. , protective film or cover film is used. As a result, it is possible to manufacture a display device having a high-quality cured film with high productivity.

實施例 Example

以下,藉由實施例更詳細說明本發明。例中之「%」及「份」,若無特別限定,是表示質量%及質量份。 Hereinafter, the present invention will be described in more detail by way of examples. The "%" and "parts" in the examples are mass% and mass parts unless otherwise specified.

在備有回流冷卻器、滴下漏斗及攪拌機之燒瓶內,以氮氣0.02L/分鐘之流速作成氮氣環境,放入二乙二醇乙基甲基醚140份,一面攪拌一面加熱到70℃。其次將甲基丙烯酸40份:以及單體(I-1)及單體(II-1)的混合物{混合物中的單體(I-1):單體(II-1)的莫耳比=50:50}360份,溶解到二乙二醇乙基甲基醚190份中調製溶液,將此溶液,使用滴下泵花4小時,滴下到保溫在70℃之燒瓶內。 In a flask equipped with a reflux condenser, a dropping funnel and a stirrer, a nitrogen atmosphere was set at a flow rate of 0.02 L/min of nitrogen gas, and 140 parts of diethylene glycol ethyl methyl ether was placed, and the mixture was heated to 70 ° C while stirring. Next, 40 parts of methacrylic acid: and a mixture of monomer (I-1) and monomer (II-1) {monomer (I-1) in the mixture: molar ratio of monomer (II-1) = 50:50} 360 parts, dissolved in 190 parts of diethylene glycol ethyl methyl ether to prepare a solution, which was sprayed for 4 hours using a drip pump, and dropped into a flask kept at 70 ° C.

另一方面,將聚合起始劑2,2'-偶氮雙(2,4-二甲基戊腈)30份溶解到二乙二醇乙基甲基醚240份的溶液,使用別的滴下泵花5小時,滴下到燒瓶內。終止聚合起始劑溶液之滴下後,在70℃保持4小時,之後冷卻到室溫,得到固形分42.3%的共聚合物(樹脂Aa)的溶液。得到的樹脂Aa之重量平均分子量(Mw)是8000、分子量分布(Mw/Mn)是1.91,固形分換算的酸價是60mg-KOH/g。樹脂Aa是有下述之結構單元。 On the other hand, 30 parts of the polymerization initiator 2,2'-azobis(2,4-dimethylvaleronitrile) was dissolved in a solution of 240 parts of diethylene glycol ethyl methyl ether, and other drops were used. The pump was pumped for 5 hours and dripped into the flask. After the dropwise addition of the polymerization initiator solution was terminated, it was kept at 70 ° C for 4 hours, and then cooled to room temperature to obtain a solution of a solid polymer (resin Aa) of 42.3%. The obtained resin Aa had a weight average molecular weight (Mw) of 8,000, a molecular weight distribution (Mw/Mn) of 1.91, and an acid value in terms of a solid content of 60 mg-KOH/g. The resin Aa has the following structural unit.

所得到樹脂的重量平均分子量(Mw)及數平均分子量(Mn)之測定,係使用GPC法,用以下之條件進行。 The weight average molecular weight (Mw) and the number average molecular weight (Mn) of the obtained resin were measured by the GPC method under the following conditions.

裝置:K2479((股)島津製作所製) Device: K2479 (made by Shimadzu Corporation)

管柱:SHIMADZU Shim-pack GPC-80M Column: SHIMADZU Shim-pack GPC-80M

管柱溫度:40℃ Column temperature: 40 ° C

溶劑:THF(四氫呋喃) Solvent: THF (tetrahydrofuran)

流速:1.0 mL/min Flow rate: 1.0 mL/min

檢出器:RI Detector: RI

校正用標準物質:TSK Standard Polystyrene F-40、F-4、F-288、 A-2500、A-500(TOSOH(股)製) Standard materials for calibration: TSK Standard Polystyrene F-40, F-4, F-288, A-2500, A-500 (TOSOH (share) system)

將上述得到換算聚苯乙烯之重量平均分子量及數平均分子量的比(Mw/Mn)當作分子量分布。 The ratio (Mw/Mn) of the weight average molecular weight and the number average molecular weight of the above-mentioned converted polystyrene was taken as a molecular weight distribution.

實施例1至5及比較例1 Examples 1 to 5 and Comparative Example 1 〈硬化性樹脂組成物之調製〉 <Modulation of Curable Resin Composition>

將表1所示各成分、以表1所示比率混合,而得到硬化性樹脂組成物。 Each component shown in Table 1 was mixed at the ratio shown in Table 1, and the curable resin composition was obtained.

又,表1中,樹脂(A)的含有份數是以固形分換算之質量份表示。 Further, in Table 1, the content of the resin (A) is expressed by parts by mass in terms of solid content.

樹脂(A);Aa;樹脂Aa Resin (A); Aa; Resin Aa

(甲基)丙烯酸系化合物(B);二季戊四醇六丙烯酸酯(KAYARD(註冊商標)DPHA;日本化藥(股)製) (meth)acrylic compound (B); dipentaerythritol hexaacrylate (KAYARD (registered trademark) DPHA; manufactured by Nippon Kayaku Co., Ltd.)

環氧樹脂(C);雙酚A型環氧樹脂(JER157S70;三菱 化學(股)製) Epoxy resin (C); bisphenol A type epoxy resin (JER157S70; Mitsubishi Chemical (share) system)

聚合起始劑(D);Da;N-苯醯氧基-1-(4-苯基硫基苯基)辛烷-1-酮-2-亞胺(Irgacure(註冊商標)OXE01;BASF公司製;O-醯基肟化合物) Polymerization initiator (D); Da; N-benzofluorenyl-1-(4-phenylthiophenyl)octane-1-one-2-imine (Irgacure (registered trademark) OXE01; BASF Corporation System; O-mercaptopurine compound)

聚合起始劑(D);Db;2,2'-雙(2-氯苯基)-4,4',5,5'-四苯基-1,2'-聯咪唑(B-CIM;保土谷化學(股)製;聯咪唑化合物) Polymerization initiator (D); Db; 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenyl-1,2'-biimidazole (B-CIM; Baotu Valley Chemical Co., Ltd.; biimidazole compound)

聚合起始劑(D1);2-[2-氧基-2-(萘基)亞乙基]-3-甲基苯并噻唑啉(以下述表示的化合物) Polymerization initiator (D1); 2-[2-oxy-2-(naphthyl)ethylidene]-3-methylbenzothiazoline (compound represented below)

硫醇化合物(T):季戊四醇肆丙酸酯(PEMP;SC有機化學(股)製) Thiol compound (T): pentaerythritol phthalate (PEMP; SC organic chemistry)

抗氧化劑(F);1,3,5-參(4-羥基-3,5-二-三級-丁基苄基)-1,3,5-三嗪-2,4,6-(1H,3H,5H)-三酮(IRGANOX(註冊商標)3114;BASF公司製) Antioxidant (F); 1,3,5-gin (4-hydroxy-3,5-di-tertiary-butylbenzyl)-1,3,5-triazine-2,4,6-(1H , 3H, 5H)-trione (IRGANOX (registered trademark) 3114; manufactured by BASF Corporation)

多價羧酸(G);丁烷四羧酸(Rikacid BT-W;新日本理化(股)公司) Polyvalent carboxylic acid (G); butane tetracarboxylic acid (Rikacid BT-W; New Japan Physical and Chemical Corporation)

咪唑化合物(J);1-苄基-2-苯基咪唑(Curezol 1B2PZ;四國化成工業(股)製) Imidazole compound (J); 1-benzyl-2-phenylimidazole (Curezol 1B2PZ; Shikoku Chemical Industry Co., Ltd.)

界面活性劑(H);聚醚改質矽油(Toray silicon SH8400;Toray Dowcorning(股)製) Surfactant (H); polyether modified oyster sauce (Toray silicon SH8400; Toray Dowcorning (manufactured by the company)

溶劑(E):Ea;二乙二醇乙基甲基醚 Solvent (E): Ea; diethylene glycol ethyl methyl ether

溶劑(E):Eb;丙二醇單甲基醚(蒸發速度:62) Solvent (E): Eb; propylene glycol monomethyl ether (evaporation rate: 62)

溶劑(E):Ec;丙二醇單甲基醚醋酸酯(蒸發速度:33) Solvent (E): Ec; propylene glycol monomethyl ether acetate (evaporation rate: 33)

溶劑(E):Ed;3-甲氧基-1-丁醇(蒸發速度:12) Solvent (E): Ed; 3-methoxy-1-butanol (evaporation rate: 12)

溶劑(E)是硬化性樹脂組成物之固形分量試圖成為表1之「固形分量%」方式混合,溶劑(E)中的溶劑成分(Ea)至(Eb)的值,表示溶劑(E)中的質量比%。 The solvent (E) is a solid component of the curable resin composition which is intended to be mixed as "solid component %" of Table 1, and the solvent components (Ea) to (Eb) in the solvent (E) represent the solvent (E). The quality ratio is %.

〈溶劑之蒸發速度測定〉 <Measurement of evaporation rate of solvent>

在可能供給氮氣之抽氣櫃(hood)內,設置化學天秤、及放入2號濾紙(70mmψ)之70mmψ盤2個,一邊是醋酸n-丁酯,另一邊是試料,分別放入1.0g,在抽氣櫃內,以30NL/ml的流速供給氮氣,醋酸n-丁酯及試料的重量是每經過60秒鐘同時測定的方法,將由經過60秒鐘、120秒鐘、180秒鐘的重量分別算出蒸發速度。將此之平均值當作試料的蒸發速度。 In a hood that may supply nitrogen gas, set up a chemical scale and two 70mm trays of No. 2 filter paper (70mm ψ), one side is n-butyl acetate, the other side is a sample, and each is placed in 1.0g. In the extraction cabinet, nitrogen gas is supplied at a flow rate of 30 NL/ml. The weight of n-butyl acetate and the sample is measured simultaneously every 60 seconds, and will be 60 seconds, 120 seconds, and 180 seconds. The evaporation rate was calculated from the weight. The average value was taken as the evaporation rate of the sample.

將在實施例及比較例的硬化性樹脂組成物中所含的溶劑(E)當作試料測定,將醋酸丁酯的蒸發速度當作100時的蒸發速度於表2中表示。 The solvent (E) contained in the curable resin composition of the examples and the comparative examples was measured as a sample, and the evaporation rate at the time when the evaporation rate of butyl acetate was taken as 100 was shown in Table 2.

〈黏度測定〉 <Viscometry>

有關所得之硬化性樹脂組成物,分別,使用黏度計(機種:TV-30:東機產業(股)製),測定黏度。將結果在表4中表示。 The viscosity of the obtained curable resin composition was measured using a viscometer (model: TV-30: manufactured by Toki Sangyo Co., Ltd.). The results are shown in Table 4.

〈組成物的透過率測定〉 <Measurement of transmittance of composition>

有關得到之硬化性樹脂組成物,分別使用紫外可見光近紅外光光度計(V-650;日本分光(股)製)(石英管,光路長;1cm),測定400至700nm中之平均透過率(%)。將結果在表4中表示。 For the obtained curable resin composition, an ultraviolet visible light near-infrared luminometer (V-650; manufactured by JASCO Corporation) (quartz tube, optical path length; 1 cm) was used to measure the average transmittance in 400 to 700 nm ( %). The results are shown in Table 4.

〈硬化膜的製作〉 <Production of cured film>

將2吋四方之玻璃基板(Eagle XG,Corning公司製)用中性洗劑、水、異丙醇順序洗淨後乾燥,在此玻璃基板上,將硬化性樹脂組成物以後烤後之膜厚試圖成2.0μm的方式旋轉塗布,其次在乾淨烘箱中90℃預烤10分鐘。之後,以230℃後烘烤40分鐘而得到硬化膜。 A 2" square glass substrate (Eagle XG, manufactured by Corning) was washed with a neutral detergent, water, and isopropyl alcohol, and dried, and the thickness of the curable resin composition was baked on the glass substrate. An attempt was made to spin coat in a 2.0 μm manner, followed by pre-baking at 90 ° C for 10 minutes in a clean oven. Thereafter, it was post-baked at 230 ° C for 40 minutes to obtain a cured film.

〈膜厚測定〉 <Measurement of film thickness>

硬化膜的膜厚,係使用接觸式膜厚測定裝置(DEKTAK 6M;Arpak(股)製),測定寬度500μm,以測定速度10秒來測定。 The film thickness of the cured film was measured using a contact film thickness measuring device (DEKTAK 6M; manufactured by Arpak Co., Ltd.) to measure a width of 500 μm at a measurement speed of 10 seconds.

〈硬化膜的透過率測定〉 <Measurement of Transmittance of Hardened Film>

將得到之硬化膜,使用顯微分光測定裝置(OSP-SP200;OLYMPUS公司製),測定在400nm中透過率(%)及400至700nm中的平均透過率(%)。將結果在表4中表示。 The obtained cured film was measured for transmittance (%) at 400 nm and average transmittance (%) at 400 to 700 nm using a microscopic spectrometer (OSP-SP200; manufactured by OLYMPUS). The results are shown in Table 4.

〈減壓乾燥時間的評估〉 <Evaluation of Decompression Drying Time>

將15cm四方之ITO成膜玻璃基板上,將硬化性樹脂組成物使用狹縫鑄模塗布機(Takudai-100伊藤忠產機(股)公司製),以後烤後之膜厚試圖成為1.5μm的條件來塗布。之後,在減壓乾燥機(VCD Macrotec(股)公司製)滾筒泵回轉數為1000rpm, 增壓泵回轉數為700rpm,測定常溫25℃的條件下達到減壓度66Pa為止的時間,減壓乾燥時間短時,由於硬化膜的生產性變高而有利,將結果在表4中表示。 A 15 cm square ITO film-forming glass substrate was used, and the curable resin composition was subjected to a slit mold coater (Takudai-100, manufactured by Itoji Co., Ltd.), and the film thickness after baking was attempted to be 1.5 μm. Coating. After that, the number of revolutions of the drum pump in a vacuum dryer (VCD Macrotec Co., Ltd.) was 1000 rpm. The number of revolutions of the booster pump was 700 rpm, and the time until the pressure reduction of 66 Pa was reached under the condition of a normal temperature of 25 ° C. When the vacuum drying time was short, the productivity of the cured film was high, and the results are shown in Table 4.

〈狹縫噴嘴乾燥性評估〉 <Slot Nozzle Dryness Evaluation>

將15cm四方之ITO成膜玻璃基板上,使用狹縫鑄模塗布機(Takudai-100伊藤忠產機(股)公司製),以試圖後烤後之膜厚成為1.5μm的條件,塗布硬化性樹脂組成物。 A 15 cm square ITO film-forming glass substrate was coated with a curable resin by using a slit mold coater (Takudai-100, manufactured by Itochu Co., Ltd.) under the condition that the film thickness after baking was 1.5 μm. Things.

之後,將狹縫鑄模塗布機的噴嘴,直接放置1分鐘後,在不洗淨該噴嘴尖端下,與前述同樣操作,在15cm四方之ITO成膜玻璃基板上,塗布硬化性樹脂組成物。 Thereafter, the nozzle of the slit die coater was directly placed for 1 minute, and then the curable resin composition was applied onto a 15 cm square ITO film-forming glass substrate in the same manner as described above without washing the nozzle tip.

將不洗淨該噴嘴尖端塗布硬化性樹脂組成物之基板,以減壓乾燥機(VCD Macrotec(股)公司製)減壓度變成為0.5 torr為止使其減壓乾燥,接著,在熱盤上,於90℃預烤2分鐘形成組成物層。 The substrate of the curable resin composition was applied to the tip of the nozzle, and the pressure reduction dryer (VCD Macrotec Co., Ltd.) was used to reduce the pressure to 0.5 torr, and then dried under reduced pressure, and then on a hot plate. The composition layer was formed by prebaking at 90 ° C for 2 minutes.

放冷,將組成物層表面照射Na燈,以目視觀察組成物層面。只確認有縱線斑紋的情形是當作X,僅僅可以確認的情形是當作△,不能確認的情形是當作○,將結果在表4中表示。 After cooling, the surface of the composition layer was irradiated with a Na lamp to visually observe the composition level. Only the case where the vertical line streak is confirmed is regarded as X, and the case where it can be confirmed is regarded as Δ, and the case where it cannot be confirmed is regarded as ○, and the result is shown in Table 4.

〈平坦性評估;評估用基板的製作〉 <Flatness evaluation; production of evaluation substrate>

將在表3所示各成分,以表3所示之比率混合,得到著色感光性樹脂組成物。 The components shown in Table 3 were mixed at a ratio shown in Table 3 to obtain a colored photosensitive resin composition.

將15cm四方的經ITO成膜之玻璃基板,由中性洗劑、水、異丙醇順序洗淨後乾燥,在此基板上,將著色感光樹脂組成物,試圖後烤後膜厚成為1.6μm方式以旋轉塗布。其次,在經濟烘箱中,以90℃預烤3分鐘,形成著色組成層。放冷,使基板上的著色組成物層與石英玻璃製光罩的間隔設成100μm,使用曝光機(TME-150RSK;Topcon(股)製,光源;超高壓水銀燈),在大氣環境下,以100mJ/cm2的曝光量(365nm為基準)照射光。又,將此之光照射自超高壓水銀燈放射光,使通過光學濾光片(UV-35;Asahi tecnoglass(股)製)。又,作為光罩者,是使用為了形成線寬30μm的線與空間圖案之光罩。將光照射後的著色組成物層,在含有非離子系界面活性劑0.12%與氫氧化鉀0.04%之水系顯影液中23℃浸漬80秒鐘顯影,水洗後,烘箱中,進行在220℃ 20分鐘的後烘烤,形成線寬30μm的線與空間之著色圖案,作成評 估用的基板。 A 15 cm square ITO-formed glass substrate was sequentially washed with a neutral detergent, water, and isopropyl alcohol, and then dried. On the substrate, the photosensitive resin composition was colored, and the film thickness after the baking was attempted to be 1.6 μm. The way is to spin coating. Next, in an economical oven, prebaking at 90 ° C for 3 minutes to form a colored composition layer. After cooling, the distance between the colored composition layer on the substrate and the quartz glass mask was set to 100 μm, and an exposure machine (TME-150RSK; Topcon (light source; ultrahigh pressure mercury lamp) was used in an atmosphere, Light was irradiated with an exposure amount of 100 mJ/cm 2 (based on 365 nm). Further, this light was irradiated with light from an ultrahigh pressure mercury lamp to pass through an optical filter (UV-35; manufactured by Asahi tecnoglass Co., Ltd.). Further, as a mask, a mask for forming a line and space pattern having a line width of 30 μm was used. The colored composition layer after the light irradiation was immersed in an aqueous developing solution containing 0.12% of a nonionic surfactant and 0.04% of potassium hydroxide in a water-based developing solution at 23 ° C for 80 seconds, and washed with water, and then, in an oven, at 220 ° C. After the minute baking, a colored pattern of lines and spaces having a line width of 30 μm was formed, and a substrate for evaluation was prepared.

〈平坦性評估1〉 <Flatness Evaluation 1>

在前述評估用的基板中,使用狹縫塗布機(Takudai-100伊藤忠產機(股)公司製),以後烤後的膜厚試圖成為1.5μm之條件塗布硬化性樹脂組成物。之後,減壓乾燥機(VCD Macrotec(股)公司製)減壓度變成為0.5 torr為止使其減壓乾燥,在熱盤上,於90℃預烤2分鐘,放冷,在230℃藉由後烤40分鐘,形成硬化膜。 In the substrate for the evaluation, a slit coater (Takudai-100, manufactured by Itoji Co., Ltd.) was used, and the film thickness after baking was applied to a condition of 1.5 μm to apply a curable resin composition. Then, the pressure reduction dryer (VCD Macrotec Co., Ltd.) was vacuum-dried at a reduced pressure of 0.5 torr, pre-baked at 90 ° C for 2 minutes on a hot plate, and allowed to cool, at 230 ° C. After baking for 40 minutes, a cured film was formed.

評估用基板的硬化膜中,測定硬化膜之下未形成著色圖案部分的膜厚,確認是1.5μm。 In the cured film of the evaluation substrate, the film thickness of the portion where the colored pattern was not formed under the cured film was measured, and it was confirmed to be 1.5 μm.

測定在著色圖案上所形成的硬化膜表面的起伏高低差,若該高低差為0.5μm以下的話,硬化膜之平坦性很好,尤其是適於作為彩色濾光片用保護膜。將結果在表4中表示。 The undulation difference of the surface of the cured film formed on the colored pattern is measured. When the height difference is 0.5 μm or less, the flatness of the cured film is excellent, and it is particularly suitable as a protective film for a color filter. The results are shown in Table 4.

〈平坦性評估2〉 <Flatness Evaluation 2>

在前述評估用的基板中,使用狹縫塗布機(Takudai-100伊藤忠產機(股)公司製),以後烤後的膜厚試圖成為1.5μm之條件塗布硬化性樹脂組成物。之後,減壓乾燥機(VCD Macrotec(股)公司製)減壓度變成為0.5 torr為止使其減壓乾燥,在熱盤上,於90℃預烤2分鐘,放冷後,使用曝光機(TME-150RSK;Topcon(股)製,光源;超高壓水銀燈),在大氣環境下,以250mJ/cm2的曝光量(365nm為基準)照射光。又,此之光照射自超高壓水銀燈放射光,使通過光學濾光片(UV-35;Asahi tecnoglass(股)製)。將光照射後之組成物層,在含有非離子系界面活性劑0.12%與氫氧化鉀0.04%之水系顯影液中於25℃浸漬60秒鐘顯影,水洗後,進行在230℃ 20分鐘的後烤,形成硬化膜。 In the substrate for the evaluation, a slit coater (Takudai-100, manufactured by Itoji Co., Ltd.) was used, and the film thickness after baking was applied to a condition of 1.5 μm to apply a curable resin composition. After that, the pressure reduction dryer (manufactured by VCD Macrotec Co., Ltd.) was dried under reduced pressure until it became 0.5 torr, and prebaked on a hot plate at 90 ° C for 2 minutes. After cooling, the exposure machine was used. TME-150RSK; Topcon (source), light source; ultra-high pressure mercury lamp), irradiated with light at an exposure of 250 mJ/cm 2 (based on 365 nm) in an atmospheric environment. Further, the light is irradiated from the ultrahigh pressure mercury lamp to pass through an optical filter (UV-35; manufactured by Asahi tecnoglass). The composition layer after the light irradiation was immersed in an aqueous developing solution containing 0.12% of a nonionic surfactant and 0.04% of potassium hydroxide at 25 ° C for 60 seconds, and after washing with water, at 230 ° C for 20 minutes. Bake to form a cured film.

評估用基板上的硬化膜中,測定硬化膜之下未形成著色圖案部分的膜厚,確認是1.5μm。 In the cured film on the evaluation substrate, the film thickness of the colored pattern portion under the cured film was measured, and it was confirmed to be 1.5 μm.

測定在著色圖案上所形成的硬化膜表面的起伏高低差,若該高低差為0.5μm以下的話,硬化膜之平坦性很好,尤其是適於作為彩色濾光片用保護膜。將結果在表4中表示。 The undulation difference of the surface of the cured film formed on the colored pattern is measured. When the height difference is 0.5 μm or less, the flatness of the cured film is excellent, and it is particularly suitable as a protective film for a color filter. The results are shown in Table 4.

〈解像性評估〉 <Resolution Evaluation>

作為基板者,是使用2吋平方的玻璃基板(Eagle XG,Corning公司製),除了在曝光之際是隔著光罩以100mJ/cm2的曝光量(365nm為基準)照射光之外,其餘與平坦性評估2同樣操作,製作有圖案之硬化膜。尚且,作為光罩者,係使用形成20μm線與空間圖案之光罩。 As a substrate, a 2 Å square glass substrate (Eagle XG, manufactured by Corning Co., Ltd.) was used, except that the light was irradiated with an exposure amount of 100 mJ/cm 2 (based on 365 nm) through a photomask. A patterned cured film was produced in the same manner as in the flatness evaluation 2. Further, as a photomask, a photomask which forms a line pattern of 20 μm is used.

得到的硬化膜是使用掃描型電子顯微鏡(S-4000;日立Heightecnolygy(股)製),觀察前述圖案,若解像20μm線與空間則當作○,若無解像的話當作X。將結果在表4表示。 The obtained cured film was observed by a scanning electron microscope (S-4000; manufactured by Hitachi High-Technology Co., Ltd.), and was regarded as ○ when the solution was 20 μm in line and space, and as X when there was no image. The results are shown in Table 4.

由表4之結果,確認本發明之硬化性樹脂組成物是減壓乾燥時間短,再者硬化膜之平坦性也優異。為此,藉由本發明之硬化性樹脂組成物,可以製造生產性良好,高性能的硬化膜。 From the results of Table 4, it was confirmed that the curable resin composition of the present invention has a short drying time under reduced pressure, and the flatness of the cured film is also excellent. Therefore, the curable resin composition of the present invention can produce a cured film having high productivity and high performance.

依據本發明,可以提供在基板上塗布硬化性樹脂組成物後,減壓乾燥之際為乾燥時間短的硬化性樹脂組成物。由該硬化性樹脂組成物得到之硬化膜,由於是平坦性優異,故可以適合顯示裝置等使用。 According to the present invention, it is possible to provide a curable resin composition which has a short drying time when the curable resin composition is applied onto a substrate and then dried under reduced pressure. Since the cured film obtained from the curable resin composition is excellent in flatness, it can be suitably used for a display device or the like.

Claims (6)

一種硬化性樹脂組成物,包含具硬化性的樹脂及溶劑,其中,溶劑是含有二烷二醇二烷基醚,與溶劑(E1),與溶劑(E2),二烷二醇二烷基醚的含量,相對於溶劑的總量,是1質量%以上及45質量%以下,溶劑(E1):與二烷二醇二烷基醚不同,並且蒸發速度是將醋酸丁酯的蒸發速度當作100時,為40以上及100以下的醚溶劑,溶劑(E2):與二烷二醇二烷基醚不同,並且蒸發速度是將醋酸丁酯的蒸發速度當作100時,為13以上及未達40的醚酯溶劑。 A curable resin composition comprising a curable resin and a solvent, wherein the solvent contains a dialkyl glycol dialkyl ether, and a solvent (E1), a solvent (E2), a dialkyl glycol dialkyl ether The content is 1% by mass or more and 45% by mass or less based on the total amount of the solvent, and the solvent (E1) is different from the dialkyl glycol dialkyl ether, and the evaporation rate is regarded as the evaporation rate of butyl acetate. At 100 hours, it is an ether solvent of 40 or more and 100 or less. The solvent (E2) is different from the dialkyl glycol dialkyl ether, and the evaporation rate is 13 or more when the evaporation rate of butyl acetate is taken as 100. Up to 40 ether ester solvent. 如申請專利範圍第1項所述之硬化性樹脂組成物,其中,具硬化性的樹脂為包含源自由不飽和羧酸及不飽和羧酸酐所成群組中選出之至少1種的結構單元,與源自具有碳數2至4的環狀醚結構及烯性不飽和鍵的單體之結構單元的共聚合物。 The curable resin composition according to claim 1, wherein the curable resin is a structural unit containing at least one selected from the group consisting of a source of a free unsaturated carboxylic acid and an unsaturated carboxylic anhydride. A copolymer with a structural unit derived from a monomer having a cyclic ether structure having 2 to 4 carbon atoms and an ethylenically unsaturated bond. 如申請專利範圍第1或2項所述之硬化性樹脂組成物,其復含有抗氧化劑。 The curable resin composition according to claim 1 or 2, which further comprises an antioxidant. 一種硬化膜,由申請專利範圍第1至3項中任一項所述之硬化性樹脂組成物所形成。 A cured film formed of the curable resin composition according to any one of claims 1 to 3. 一種顯示裝置,含有申請專利範圍第4項所述之硬化膜。 A display device comprising the cured film of claim 4 of the patent application. 一種硬化膜的製造方法,含有:(1)將申請專利範圍第1至3項中任一項所述之硬化性樹脂組成物塗布在基板上之步驟,(2)將經塗布之硬化性樹脂組成物減壓乾燥,形成組成物層的 步驟,(3)將組成物層加熱的步驟。 A method for producing a cured film, comprising: (1) a step of applying a curable resin composition according to any one of claims 1 to 3 to a substrate, and (2) applying the curable resin The composition is dried under reduced pressure to form a composition layer Step, (3) a step of heating the composition layer.
TW101140949A 2011-11-07 2012-11-05 Curable resin composition TWI559076B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011243145 2011-11-07

Publications (2)

Publication Number Publication Date
TW201335696A TW201335696A (en) 2013-09-01
TWI559076B true TWI559076B (en) 2016-11-21

Family

ID=48414664

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101140949A TWI559076B (en) 2011-11-07 2012-11-05 Curable resin composition

Country Status (4)

Country Link
JP (1) JP6175754B2 (en)
KR (1) KR102018919B1 (en)
CN (1) CN103116244B (en)
TW (1) TWI559076B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102380577B1 (en) * 2016-05-27 2022-03-29 스미또모 가가꾸 가부시끼가이샤 Resin composition and cured film
KR102622128B1 (en) * 2016-09-19 2024-01-09 동우 화인켐 주식회사 Photosensitive resin comopsition and photocurable protective layer formed from the same
JP7509080B2 (en) 2020-04-30 2024-07-02 Jsr株式会社 Radiation-sensitive composition, method for producing cured film, semiconductor device, and display device
TW202440657A (en) * 2023-03-08 2024-10-16 日商住友化學股份有限公司 Composition, laminate and display device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110039117A1 (en) * 2008-04-14 2011-02-17 Showa Denko K.K. Cured film and method for production thereof
CN1881080B (en) * 2005-06-15 2011-06-08 Jsr株式会社 Photosensitive resin composition, partition of display panel and display panel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4661384B2 (en) * 2005-06-16 2011-03-30 Jsr株式会社 Radiation-sensitive composition for forming colored layer and color filter
JP4656025B2 (en) * 2006-08-31 2011-03-23 Jsr株式会社 Radiation-sensitive composition for forming colored layer and color filter
CN101206402A (en) * 2006-12-22 2008-06-25 住友化学株式会社 Photosensitive resin composition
TWI559079B (en) * 2008-11-18 2016-11-21 Sumitomo Chemical Co Photosensitive resin composition and display device
TWI521300B (en) * 2008-11-18 2016-02-11 Sumitomo Chemical Co Photosensitive resin composition and display device
JP2011022557A (en) * 2009-06-19 2011-02-03 Sumitomo Chemical Co Ltd Photosensitive resin composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1881080B (en) * 2005-06-15 2011-06-08 Jsr株式会社 Photosensitive resin composition, partition of display panel and display panel
US20110039117A1 (en) * 2008-04-14 2011-02-17 Showa Denko K.K. Cured film and method for production thereof

Also Published As

Publication number Publication date
KR20130050241A (en) 2013-05-15
CN103116244A (en) 2013-05-22
TW201335696A (en) 2013-09-01
CN103116244B (en) 2018-11-13
KR102018919B1 (en) 2019-09-05
JP6175754B2 (en) 2017-08-09
JP2013122576A (en) 2013-06-20

Similar Documents

Publication Publication Date Title
TWI617885B (en) Colored photosensitive resin composition
TWI738750B (en) Curable resin composition and protective film
TWI570511B (en) Coloring the photosensitive resin composition
TWI608299B (en) Curable resin composition
TW201335715A (en) Photosensitive resin composition
TWI559076B (en) Curable resin composition
JP6192898B2 (en) Curable resin composition
CN107434941B (en) Resin composition and cured film
TW201303489A (en) Photosensitive resin composition
TWI571456B (en) Photosensitive resin composition
CN103676480A (en) Photosensitive resin composition
TW201837070A (en) Resin composition, film and copolymer
JP2012018374A (en) Photosensitive resin composition
TWI754008B (en) Red colored composition
WO2020162007A1 (en) Colored curable resin composition
TWI566040B (en) Photosensitive resin composition
JP6212952B2 (en) Curable resin composition
JP6079109B2 (en) Method for manufacturing protective film
JP6187010B2 (en) Curable resin composition
TW201617392A (en) Curable resin composition